data_2k9k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k9k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.786 0.327 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' ASN . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.421 HE21 ' N ' ' A' ' 197' ' ' THR . 34.1 tp60 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.421 ' N ' HE21 ' A' ' 196' ' ' GLN . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.828 0.347 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.3 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.75 0.309 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.812 0.339 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.46 ' HH ' ' N ' ' A' ' 203' ' ' LYS . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.46 ' N ' ' HH ' ' A' ' 129' ' ' TYR . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.473 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.756 0.312 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.435 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 183' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.76 0.314 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.766 0.317 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.45 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.773 0.321 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 32.7 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.459 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.538 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.752 0.31 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 121' ' ' PRO . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.773 0.32 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.522 ' C ' ' OD1' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.431 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.334 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.762 0.315 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.417 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.778 0.323 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.486 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.494 ' NE2' HE21 ' A' ' 196' ' ' GLN . 9.2 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.494 HE21 ' NE2' ' A' ' 193' ' ' GLN . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.804 0.335 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.612 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.421 ' HB2' ' CB ' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.832 0.348 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 166' ' ' ARG . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.671 ' N ' HD22 ' A' ' 163' ' ' ASN . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.76 0.314 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 151' ' ' THR . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.411 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.764 0.316 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.709 0.29 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.405 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 129' ' ' TYR . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.739 0.304 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.402 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 199' ' ' THR . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.512 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 163' ' ' ASN . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.424 ' CG ' ' HG3' ' A' ' 121' ' ' PRO . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.792 0.329 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.819 0.343 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.6 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.817 0.341 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.48 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.768 0.318 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -121.02 69.73 18.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.605 0.717 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.76 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.239 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -63.74 152.8 38.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 114.42 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -169.97 166.65 9.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.24 160.4 39.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.52 0.676 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 168.19 22.3 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.34 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.1 p -104.85 -71.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -123.83 -179.16 4.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.12 141.46 15.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.58 161.02 33.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.366 . . . . 0.0 110.878 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -163.56 153.25 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.24 95.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.9 p -79.53 -41.25 27.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -54.39 146.68 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -89.95 100.12 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -127.4 171.71 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.67 107.83 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.083 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 163' ' ' ASN . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 76.56 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -128.83 110.33 12.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.25 112.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.11 154.13 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.81 107.85 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.72 -63.11 0.52 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -119.29 108.49 14.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -110.94 -169.77 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.04 179.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.421 HE21 ' N ' ' A' ' 197' ' ' THR . 34.1 tp60 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.421 ' N ' HE21 ' A' ' 196' ' ' GLN . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.81 142.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -52.13 151.95 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.6 mttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -114.83 72.82 2.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.571 0.701 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 165.82 29.6 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -118.62 155.43 30.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 t -153.34 112.92 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.133 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -103.26 76.66 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.1 73.21 12.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.555 0.693 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 138.73 38.44 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.9 p -115.0 160.05 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -170.09 118.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.2 129.31 5.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.68 119.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -175.62 168.29 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.88 110.15 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 t -84.27 -48.91 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.67 56.59 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 71.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -171.71 145.6 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.9 103.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 75.93 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.92 115.93 17.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.7 mt -85.07 116.75 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.84 152.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -51.83 108.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.85 -35.34 3.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -146.56 110.69 5.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -119.48 -170.22 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.55 178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 193' ' ' GLN . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.3 mm -64.3 143.33 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.99 145.08 17.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.862 0.363 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.87 157.26 31.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.06 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -74.54 -28.51 60.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m 64.31 42.35 5.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -56.59 144.96 29.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.22 72.51 1.41 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -43.42 2.67 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 p 49.93 42.63 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -62.14 146.21 51.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.75 -151.78 24.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.529 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -148.47 173.93 12.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.24 -74.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.13 157.71 7.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -85.81 -28.5 24.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.42 34.78 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -127.49 59.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.2 163.65 2.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.62 104.04 10.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 90.44 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -142.47 102.82 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.67 116.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.58 152.55 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.33 107.95 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.06 -34.39 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.487 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -151.38 112.93 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.54 -169.68 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.87 178.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.6 140.76 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -57.22 104.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.9 tttm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -156.89 157.28 30.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.885 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.383 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -162.71 136.91 6.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.4 p -107.03 -178.11 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 p -118.84 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -178.14 160.4 1.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.558 0.694 . . . . 0.0 111.116 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 162.75 40.8 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.677 2.252 . . . . 0.0 112.399 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 m -115.44 -44.84 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -53.53 155.97 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.12 97.39 0.74 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -175.82 122.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.359 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -174.53 163.05 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.27 159.36 9.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.3 t -67.85 -25.74 65.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 58.42 36.33 25.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.27 104.67 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -165.99 178.16 6.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.21 112.76 24.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.46 ' HH ' ' N ' ' A' ' 203' ' ' LYS . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 76.82 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -145.05 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.39 111.26 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.29 157.0 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -50.1 107.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.85 -46.13 1.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 157.17 45.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.342 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.67 -169.97 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.72 -175.85 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.46 ' N ' ' HH ' ' A' ' 129' ' ' TYR . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm -51.96 142.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.95 136.67 28.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -137.27 71.13 54.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.578 0.704 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 140.52 42.88 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -52.7 165.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.4 t -149.24 142.83 25.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 m -80.47 -31.7 37.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.7 160.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 101.3 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -63.99 -30.88 71.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -61.83 -47.17 86.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.36 66.1 1.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -115.11 120.0 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -97.15 158.12 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.49 110.81 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -81.89 -25.87 34.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.93 -48.7 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 55.66 56.5 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -79.25 153.13 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.44 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.473 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -9.12 25.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -57.2 110.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.73 115.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.27 153.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.6 108.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.9 -41.54 1.6 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.43 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -139.32 125.47 20.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -121.59 -171.96 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.069 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.87 -176.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.9 mm -78.75 143.42 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -101.88 -176.7 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.2 mttp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.869 0.366 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.21 68.03 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.57 69.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.8 103.06 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -132.05 90.29 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -96.4 126.23 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -178.03 160.45 1.25 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.698 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.31 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.6 m -157.55 136.14 11.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -93.15 -63.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.3 133.1 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -125.37 -179.26 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -86.87 -72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.6 4.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 t -79.56 -26.52 41.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -52.07 153.06 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -121.51 79.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -147.66 -176.89 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.99 104.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.435 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.435 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo -69.72 75.68 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -147.48 112.06 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.65 117.9 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.73 153.82 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.132 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.88 107.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.21 -47.0 1.04 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -140.57 152.14 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.26 -172.18 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -126.34 -173.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.54 142.96 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.43 119.1 4.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 64.48 153.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.604 0.716 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 139.19 39.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.355 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -102.94 93.77 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.7 p -76.46 112.06 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.5 m -134.85 121.5 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.29 160.39 68.01 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 111.078 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 177.49 5.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -147.81 162.72 38.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.169 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -172.6 138.0 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.97 122.89 2.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -175.69 112.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.86 150.83 43.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.12 119.79 2.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -85.52 -45.81 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.887 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -99.41 50.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -88.93 115.2 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.88 -76.51 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.97 103.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.45 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.29 32.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -53.12 111.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.81 113.31 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.33 153.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -51.42 108.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.68 -44.88 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -141.72 127.63 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -119.0 -171.99 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.79 -176.08 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.34 139.58 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.49 134.46 54.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 57.52 71.62 1.06 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.613 0.721 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 177.92 5.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -100.22 152.6 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 p -114.93 174.48 5.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 p -165.0 123.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.454 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . . . -179.27 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 107' ' ' ALA . 53.5 Cg_endo -69.71 137.52 35.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.691 2.26 . . . . 0.0 112.383 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 m -89.3 -67.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.13 -175.14 3.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.91 170.36 31.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -149.52 135.31 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -147.74 127.06 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.61 -38.0 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 t -66.1 -42.17 89.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -115.14 144.23 43.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.7 34.65 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.491 ' NE2' ' H ' ' A' ' 199' ' ' THR . 32.4 mt-30 -93.24 -178.71 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 103.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.459 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.538 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 73.55 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -125.41 114.55 18.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.17 115.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.33 153.38 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.53 108.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.77 -35.86 3.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 119.59 8.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.93 -175.93 3.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.23 178.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.491 ' H ' ' NE2' ' A' ' 118' ' ' GLN . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 141.31 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 62.49 57.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -126.58 157.27 71.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.538 0.685 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 115.77 4.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -173.91 130.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.4 p -150.94 117.56 5.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -61.5 -26.35 67.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.81 73.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.586 0.708 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 79.16 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.757 2.305 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.4 m -120.22 72.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -124.92 156.45 37.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.3 42.07 1.49 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.31 65.86 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -77.63 59.85 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.15 98.33 2.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.3 m -71.97 -26.04 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -95.45 111.73 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -113.96 107.4 15.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -106.51 -173.28 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.86 104.18 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 121' ' ' PRO . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -9.8 27.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -51.63 119.48 4.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 99.4 mt -91.35 113.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.79 153.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.157 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -51.1 107.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -30.69 3.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -146.8 148.27 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.95 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.99 -174.97 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.8 mm -80.7 140.4 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.84 178.17 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -124.57 157.33 65.8 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 172.97 11.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.246 . . . . 0.0 112.322 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.62 92.15 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -112.25 126.26 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 60.91 29.39 18.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.1 160.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 171.61 14.19 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -122.55 96.69 5.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -77.6 168.41 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.89 86.75 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -143.18 -177.79 5.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.77 179.07 5.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.13 141.75 3.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -78.46 -52.88 7.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 54.8 48.52 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -125.31 63.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -147.51 171.98 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.22 104.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.087 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 74.54 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.23 112.93 8.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.82 103.8 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.86 157.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -50.4 108.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.59 -46.81 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 161.0 39.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.05 -169.08 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.79 -175.55 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm -56.99 140.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -86.1 177.36 7.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.1 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -153.06 139.75 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.805 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 80.07 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -55.92 121.57 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.0 t -112.59 143.78 43.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.62 84.2 3.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.38 160.46 61.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -172.77 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.5 t -86.49 147.9 25.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -174.34 126.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.73 173.13 20.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -100.76 178.99 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -113.55 -29.19 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.56 89.53 1.76 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -86.02 -34.54 20.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.37 172.82 8.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.58 26.96 8.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 170.58 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.3 103.58 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.522 ' C ' ' OD1' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.431 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 92.25 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -145.0 110.44 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 42.7 mt -85.39 113.62 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.62 149.82 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -51.69 107.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.35 -34.07 4.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -144.55 129.49 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.31 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.091 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.39 -175.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm -53.02 141.89 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.75 158.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.65 157.29 77.58 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.622 0.725 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.14 28.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -110.96 121.93 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -123.25 137.13 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 t -131.13 -56.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . . . -179.2 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 107' ' ' ALA . 53.4 Cg_endo -69.77 164.98 32.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.2 m 57.68 37.07 27.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -89.93 63.68 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.18 81.98 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -109.58 82.01 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.73 159.02 21.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.11 57.89 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -79.41 -26.41 41.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -153.22 143.38 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -91.96 100.94 13.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -88.31 148.45 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.98 103.58 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.417 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -9.12 25.32 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -52.03 119.53 4.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.43 103.78 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.7 155.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -50.63 107.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.65 -56.81 0.71 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.47 157.63 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.84 -168.83 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.95 -174.92 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.7 mm -50.79 144.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.97 -174.72 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -132.04 160.6 67.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 109.52 2.34 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.366 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -91.5 -64.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -72.99 140.59 47.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -166.57 128.64 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.7 160.44 68.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.572 0.701 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -32.99 17.34 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -139.36 -179.77 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.45 -57.39 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.93 64.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.441 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.07 116.95 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -138.75 152.48 47.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.22 53.23 5.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -82.39 -49.7 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -153.51 -178.2 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -109.5 90.25 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.21 155.58 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.25 103.78 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.486 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 76.7 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -142.78 116.16 9.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.82 105.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.27 155.84 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -50.6 107.84 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.78 -46.17 1.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -139.03 152.99 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -135.81 -176.37 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.83 -175.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.494 ' NE2' HE21 ' A' ' 196' ' ' GLN . 9.2 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.494 HE21 ' NE2' ' A' ' 193' ' ' GLN . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 34.5 mm -116.44 139.17 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.6 138.69 45.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.0 pttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -166.24 68.35 1.09 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 177.17 5.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.06 120.5 35.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -117.17 110.95 18.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -144.55 115.22 7.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.06 160.44 10.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 159.93 51.6 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 m -138.39 122.45 17.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -128.52 -57.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.94 -178.1 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -151.68 111.2 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -122.28 96.13 4.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.22 60.93 0.15 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 t -85.19 -32.61 22.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -121.88 163.37 19.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -81.57 101.21 9.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -132.18 155.3 48.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.19 103.92 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.612 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.421 ' HB2' ' CB ' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.77 21.89 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -59.11 111.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.0 mt -78.62 115.56 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.39 154.46 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.135 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -51.07 108.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.56 -53.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -136.17 128.44 30.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -116.56 -169.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.32 -175.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.37 143.4 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.02 115.62 2.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -117.6 160.61 37.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.74 40.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -94.39 135.72 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -102.29 158.83 15.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 p -153.32 166.64 31.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.33 70.44 1.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.516 0.674 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.45 45.07 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.647 2.231 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.5 m -63.37 157.54 22.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.7 163.22 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.97 126.02 4.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.59 148.85 29.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -155.05 151.32 28.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.78 106.01 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 p -82.69 -54.13 5.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -73.64 165.77 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -115.88 34.45 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.18 -172.19 3.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.54 103.32 15.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 166' ' ' ARG . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.671 ' N ' HD22 ' A' ' 163' ' ' ASN . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 71.58 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -133.99 113.59 12.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.63 116.95 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.45 153.45 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.55 107.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.8 -33.38 4.45 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -145.13 133.71 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.54 -169.59 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.93 -173.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.66 142.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.84 107.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -127.21 162.54 47.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -177.38 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -151.83 -45.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m -147.09 148.52 31.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.9 m -128.69 175.63 8.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.76 73.25 0.42 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.697 . . . . 0.0 111.041 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.65 2.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.659 2.239 . . . . 0.0 112.326 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.2 t -164.01 162.65 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -147.62 175.28 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.17 161.53 34.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -145.85 158.78 43.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -174.12 138.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 24.23 21.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.0 t -65.12 -28.34 69.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.35 -171.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -80.69 -2.54 47.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 63.81 38.02 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.34 103.52 11.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.058 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 151' ' ' THR . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.411 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.94 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -130.94 117.49 19.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 81.0 mt -85.78 114.42 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.77 152.32 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.5 107.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.63 -30.92 5.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -147.61 131.42 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.22 -168.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.77 -176.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm -62.95 142.94 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.64 114.12 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.357 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -117.5 68.97 5.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 127.69 14.96 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -65.59 139.78 58.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -110.73 133.31 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.3 t -128.77 95.86 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.15 160.38 49.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.594 0.711 . . . . 0.0 111.142 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 166.83 26.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 0.0 112.361 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.7 p -70.46 -62.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -165.27 159.86 17.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.3 88.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -173.0 110.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -132.44 88.89 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.03 154.9 7.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.4 m -79.94 -46.92 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 59.59 44.22 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -98.5 67.88 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -140.58 175.47 9.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.43 103.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.405 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 129' ' ' TYR . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 76.32 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -134.2 112.44 11.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.84 115.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.66 152.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -51.07 107.28 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.86 5.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.64 126.92 21.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.15 -167.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -118.86 -174.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.15 137.17 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.35 161.37 11.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.99 159.22 31.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -178.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 0.0 112.337 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -154.05 96.9 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -134.33 123.47 24.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -155.44 177.45 11.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -137.28 160.48 65.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.575 0.703 . . . . 0.0 111.095 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 170.06 17.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 2.267 . . . . 0.0 112.311 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 p -110.79 161.58 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.2 -73.88 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.14 150.93 23.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -151.78 144.85 24.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -126.25 156.7 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.76 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 t -77.15 -55.73 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -153.34 118.81 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.54 25.11 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -153.0 174.47 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 103.73 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.402 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 199' ' ' THR . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.512 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 163' ' ' ASN . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.424 ' CG ' ' HG3' ' A' ' 121' ' ' PRO . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.2 22.99 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -51.71 106.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.0 mt -78.95 108.55 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.24 157.64 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -50.57 131.57 25.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.88 -47.87 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -148.23 143.29 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.03 -168.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -175.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -70.02 140.82 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.25 171.98 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 pttm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -136.24 160.57 66.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -173.03 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -153.49 117.69 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -165.04 153.57 12.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -157.48 135.81 11.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.1 73.82 37.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.61 0.719 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 174.97 8.76 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.66 2.24 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.0 t -152.89 140.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -146.49 169.62 18.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.73 137.57 8.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.68 124.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -155.15 167.67 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.58 135.88 2.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.5 p -85.32 -32.93 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.96 55.65 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -143.3 41.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -144.36 157.83 44.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.99 103.78 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.6 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.85 24.64 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -51.88 119.49 4.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.4 mt -92.75 122.04 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.5 153.34 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -51.74 108.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.59 -27.34 4.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -153.92 149.61 27.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.6 -169.78 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.38 -174.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.09 143.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.33 107.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 61.34 71.07 0.82 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.29 2.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -115.98 170.31 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -145.08 136.72 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.43 73.8 8.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -177.6 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.2 p -130.76 178.89 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -142.08 151.59 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.49 -114.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.88 39.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -63.6 -68.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.89 145.02 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.89 -55.59 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -91.59 120.27 32.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -136.12 -76.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -131.32 -174.32 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.56 103.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.48 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -8.42 23.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -58.11 111.64 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.8 mt -81.52 113.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.31 154.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.41 108.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.08 -50.92 0.87 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -133.91 128.09 33.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.63 -169.99 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -175.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.09 142.25 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.21 158.54 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.643 ' HB2' ' NE2' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.786 0.327 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 171' ' ' GLU . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.771 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.476 HG12 ' HE2' ' A' ' 167' ' ' MET . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 172' ' ' ALA . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.608 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.691 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 194' ' ' PRO . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 193' ' ' GLN . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.548 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 ' HG ' ' A' ' 144' ' ' LEU . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.476 ' HE2' HG12 ' A' ' 138' ' ' VAL . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.771 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.799 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.685 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.585 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 148' ' ' ILE . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 147' ' ' THR . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.643 ' NE2' ' HB2' ' A' ' 119' ' ' ALA . 6.4 tp-100 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' VAL . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.608 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 134' ' ' LEU . 45.5 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.828 0.347 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.706 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 204' ' ' ILE . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.461 HG13 ' HB1' ' A' ' 172' ' ' ALA . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 194' ' ' PRO . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.64 HD11 ' HB1' ' A' ' 119' ' ' ALA . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.675 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.756 ' HB3' HG13 ' A' ' 128' ' ' VAL . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.601 ' HA ' HD21 ' A' ' 144' ' ' LEU . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.667 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.667 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 122' ' ' LEU . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 147' ' ' THR . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 134' ' ' LEU . 50.3 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.63 ' HG3' HG21 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 171' ' ' GLU . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.663 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 204' ' ' ILE . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' HE3' ' A' ' 167' ' ' MET . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 200' ' ' VAL . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.506 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.651 HD12 ' NE2' ' A' ' 193' ' ' GLN . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 144' ' ' LEU . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.61 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.475 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.663 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HG13 ' A' ' 128' ' ' VAL . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.692 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.623 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.623 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.552 ' CB ' HD21 ' A' ' 122' ' ' LEU . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.75 0.309 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 148' ' ' ILE . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.506 HG23 ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 127' ' ' PRO . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 134' ' ' LEU . 47.2 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.812 0.339 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 130' ' ' PRO . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.45 ' CG1' ' HB1' ' A' ' 172' ' ' ALA . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.744 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 192' ' ' GLU . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 155' ' ' VAL . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.536 HG23 ' OG1' ' A' ' 147' ' ' THR . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 143' ' ' THR . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.692 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.525 ' HB3' HD11 ' A' ' 157' ' ' ILE . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.68 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.0 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 147' ' ' THR . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.695 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 198' ' ' VAL . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.708 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 163' ' ' ASN . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.598 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.802 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 194' ' ' PRO . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 192' ' ' GLU . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 146' ' ' PHE . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.512 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.546 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.653 ' HB3' HG13 ' A' ' 128' ' ' VAL . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.557 ' HA ' HD21 ' A' ' 144' ' ' LEU . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.62 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.756 ' HB2' HD21 ' A' ' 122' ' ' LEU . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.741 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.708 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.598 HG22 ' OG ' ' A' ' 145' ' ' SER . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 176' ' ' LEU . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.431 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 134' ' ' LEU . 38.9 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.705 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.756 0.312 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 204' ' ' ILE . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.791 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 194' ' ' PRO . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 192' ' ' GLU . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.671 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.625 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.637 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.453 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.79 ' HB2' HD21 ' A' ' 122' ' ' LEU . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.76 0.314 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.714 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 35.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.621 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.705 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.557 HG11 ' HG3' ' A' ' 127' ' ' PRO . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 134' ' ' LEU . 48.8 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.766 0.317 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 204' ' ' ILE . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 173' ' ' MET . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.689 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.406 HD12 ' NE2' ' A' ' 193' ' ' GLN . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 144' ' ' LEU . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 145' ' ' SER . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.645 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.428 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HB3' HG13 ' A' ' 128' ' ' VAL . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.566 ' HA ' HD21 ' A' ' 144' ' ' LEU . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.773 0.321 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.661 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.633 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' VAL . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 134' ' ' LEU . 32.7 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 204' ' ' ILE . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 172' ' ' ALA . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' A' ' 157' ' ' ILE . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 194' ' ' PRO . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 193' ' ' GLN . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.656 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.582 HG23 HD12 ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 159' ' ' VAL . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.615 ' HB3' HG13 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.524 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 146' ' ' PHE . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 1.6 tt0 -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.728 ' O ' HG22 ' A' ' 147' ' ' THR . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.592 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 134' ' ' LEU . 48.3 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.752 0.31 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.699 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 129' ' ' TYR . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 167' ' ' MET . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 159' ' ' VAL . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 173' ' ' MET . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.816 ' HB3' HD13 ' A' ' 157' ' ' ILE . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 194' ' ' PRO . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' HG2' ' A' ' 192' ' ' GLU . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 153' ' ' LYS . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.881 HD11 HD12 ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 138' ' ' VAL . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 128' ' ' VAL . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.616 ' HA ' HD21 ' A' ' 144' ' ' LEU . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.881 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.694 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.791 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.533 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.416 HG23 ' OG1' ' A' ' 143' ' ' THR . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.492 HG21 ' HA2' ' A' ' 137' ' ' GLY . 42.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.773 0.32 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 171' ' ' GLU . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE1' HD11 ' A' ' 176' ' ' LEU . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.523 HD12 ' NE2' ' A' ' 193' ' ' GLN . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 144' ' ' LEU . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.785 ' HB3' HG13 ' A' ' 128' ' ' VAL . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.439 ' HA ' HD21 ' A' ' 144' ' ' LEU . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HB2' HD21 ' A' ' 122' ' ' LEU . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.527 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.523 ' NE2' HD12 ' A' ' 148' ' ' ILE . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.672 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.449 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 171' ' ' GLU . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.428 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.515 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.618 HD11 ' HB1' ' A' ' 119' ' ' ALA . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 146' ' ' PHE . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 144' ' ' LEU . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.428 ' CE ' HG12 ' A' ' 138' ' ' VAL . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.661 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.73 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.633 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.547 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.547 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.585 ' CB ' HD21 ' A' ' 122' ' ' LEU . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.334 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.762 0.315 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 171' ' ' GLU . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 204' ' ' ILE . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 172' ' ' ALA . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.736 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 197' ' ' THR . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 194' ' ' PRO . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 119' ' ' ALA . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 146' ' ' PHE . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.736 HG22 ' HG ' ' A' ' 144' ' ' LEU . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.673 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.554 ' HB3' HG13 ' A' ' 128' ' ' VAL . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.734 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.649 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 122' ' ' LEU . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.778 0.323 . . . . 0.0 111.122 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 191' ' ' ILE . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 145' ' ' SER . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 198' ' ' VAL . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.42 HG12 ' HG3' ' A' ' 139' ' ' GLU . 48.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 182' ' ' GLN . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.667 ' CE1' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.667 HD23 ' CE1' ' A' ' 129' ' ' TYR . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 172' ' ' ALA . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 159' ' ' VAL . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 HG12 ' A' ' 142' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 155' ' ' VAL . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 153' ' ' LYS . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.786 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.581 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.554 ' HB2' HD21 ' A' ' 122' ' ' LEU . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 111.123 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.523 ' H ' HG22 ' A' ' 191' ' ' ILE . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 45.4 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.529 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 127' ' ' PRO . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 134' ' ' LEU . 34.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.804 0.335 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 123' ' ' TYR . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.433 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.763 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 202' ' ' PHE . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 199' ' ' THR . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.7 ' HB3' HD13 ' A' ' 157' ' ' ILE . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 193' ' ' GLN . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG22 ' HG ' ' A' ' 144' ' ' LEU . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.62 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.52 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.632 ' HB3' HG13 ' A' ' 128' ' ' VAL . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.442 ' HA ' HD21 ' A' ' 144' ' ' LEU . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.499 HD21 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 122' ' ' LEU . 1.7 tp-100 -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.832 0.348 . . . . 0.0 111.123 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 148' ' ' ILE . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.592 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 7.0 tp-100 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 176' ' ' LEU . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.49 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.763 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 142' ' ' VAL . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.717 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.745 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.68 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.732 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 204' ' ' ILE . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' CG1' ' HE2' ' A' ' 167' ' ' MET . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 199' ' ' THR . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.556 ' HB3' HD13 ' A' ' 157' ' ' ILE . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.514 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 192' ' ' GLU . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.628 ' HG2' HG13 ' A' ' 155' ' ' VAL . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.628 HG13 ' HG2' ' A' ' 153' ' ' LYS . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.626 HD11 HD12 ' A' ' 176' ' ' LEU . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.732 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 163' ' ' ASN . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.689 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.592 ' HB2' HD21 ' A' ' 122' ' ' LEU . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 0.0 111.155 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 2.2 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 147' ' ' THR . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.717 HE21 ' HB2' ' A' ' 119' ' ' ALA . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 176' ' ' LEU . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.745 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 134' ' ' LEU . 49.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.76 0.314 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 171' ' ' GLU . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 144' ' ' LEU . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.805 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.685 ' HB3' HD13 ' A' ' 157' ' ' ILE . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 194' ' ' PRO . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 191' ' ' ILE . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 146' ' ' PHE . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.805 HG22 ' HG ' ' A' ' 144' ' ' LEU . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.764 0.316 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.797 ' O ' HG22 ' A' ' 147' ' ' THR . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.692 HE21 ' HB2' ' A' ' 119' ' ' ALA . 30.7 mm100 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' A' ' 127' ' ' PRO . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.709 0.29 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.499 ' O ' HD23 ' A' ' 134' ' ' LEU . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.578 ' HB1' ' HE1' ' A' ' 168' ' ' PHE . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 204' ' ' ILE . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 138' ' ' VAL . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 202' ' ' PHE . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.753 HD12 HG13 ' A' ' 159' ' ' VAL . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 157' ' ' ILE . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.556 ' HG2' HG13 ' A' ' 155' ' ' VAL . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.556 HG13 ' HG2' ' A' ' 153' ' ' LYS . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 146' ' ' PHE . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.753 HG13 HD12 ' A' ' 144' ' ' LEU . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.578 ' HE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.609 ' HA ' HD21 ' A' ' 144' ' ' LEU . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HB2' HD21 ' A' ' 122' ' ' LEU . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.449 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.55 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.498 HG11 ' CD2' ' A' ' 176' ' ' LEU . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 127' ' ' PRO . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.433 ' CE1' HG21 ' A' ' 142' ' ' VAL . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 134' ' ' LEU . 30.0 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.587 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.739 0.304 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' HG21 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 171' ' ' GLU . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.652 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.699 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.402 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.76 HG11 ' CB ' ' A' ' 172' ' ' ALA . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 199' ' ' THR . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 142' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.564 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 157' ' ' ILE . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 155' ' ' VAL . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 153' ' ' LYS . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 133' ' ' ALA . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.699 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.853 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.76 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.604 ' HA ' HD21 ' A' ' 144' ' ' LEU . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 157' ' ' ILE . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.463 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.619 ' HB2' HD21 ' A' ' 122' ' ' LEU . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.792 0.329 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.587 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.564 HG22 ' OG ' ' A' ' 145' ' ' SER . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 143' ' ' THR . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.416 HG21 ' HD3' ' A' ' 127' ' ' PRO . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 134' ' ' LEU . 17.7 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.819 0.343 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.574 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 194' ' ' PRO . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 119' ' ' ALA . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 176' ' ' LEU . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.617 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.644 ' HA ' HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.569 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.817 0.341 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.534 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 176' ' ' LEU . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 204' ' ' ILE . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 172' ' ' ALA . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 194' ' ' PRO . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.56 ' HG3' HG13 ' A' ' 155' ' ' VAL . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 153' ' ' LYS . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.771 HG22 ' HG ' ' A' ' 144' ' ' LEU . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.454 ' HB3' HG13 ' A' ' 128' ' ' VAL . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.522 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' A' ' 157' ' ' ILE . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.728 ' HB2' HD21 ' A' ' 122' ' ' LEU . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.768 0.318 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.756 ' O ' HG22 ' A' ' 147' ' ' THR . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.46 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 134' ' ' LEU . 50.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -121.02 69.73 18.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.605 0.717 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.76 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.239 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -63.74 152.8 38.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 114.42 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -169.97 166.65 9.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -147.24 160.4 39.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.52 0.676 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.79 168.19 22.3 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.1 p -104.85 -71.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -123.83 -179.16 4.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.12 141.46 15.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.58 161.02 33.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.366 . . . . 0.0 110.878 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -163.56 153.25 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.24 95.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.9 p -79.53 -41.25 27.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -54.39 146.68 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -89.95 100.12 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -127.4 171.71 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.643 ' HB2' ' NE2' ' A' ' 196' ' ' GLN . . . -92.67 107.83 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.083 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 171' ' ' GLU . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.771 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.476 HG12 ' HE2' ' A' ' 167' ' ' MET . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 172' ' ' ALA . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.608 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.691 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 194' ' ' PRO . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 193' ' ' GLN . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.548 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 ' HG ' ' A' ' 144' ' ' LEU . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.476 ' HE2' HG12 ' A' ' 138' ' ' VAL . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.771 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.799 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.685 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.585 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 76.56 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -128.83 110.33 12.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.25 112.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.11 154.13 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.81 107.85 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.72 -63.11 0.52 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -119.29 108.49 14.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -110.94 -169.77 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER -114.04 179.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 148' ' ' ILE . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 147' ' ' THR . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.643 ' NE2' ' HB2' ' A' ' 119' ' ' ALA . 6.4 tp-100 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' VAL . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.608 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 134' ' ' LEU . 45.5 mm -62.81 142.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -52.13 151.95 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.6 mttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -114.83 72.82 2.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.571 0.701 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 165.82 29.6 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -118.62 155.43 30.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 t -153.34 112.92 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.133 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -103.26 76.66 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.1 73.21 12.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.555 0.693 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 138.73 38.44 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.9 p -115.0 160.05 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -170.09 118.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.2 129.31 5.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.68 119.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -175.62 168.29 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.88 110.15 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 t -84.27 -48.91 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.67 56.59 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 71.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -171.71 145.6 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -54.9 103.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.706 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 204' ' ' ILE . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.461 HG13 ' HB1' ' A' ' 172' ' ' ALA . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 194' ' ' PRO . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.64 HD11 ' HB1' ' A' ' 119' ' ' ALA . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.675 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.756 ' HB3' HG13 ' A' ' 128' ' ' VAL . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.601 ' HA ' HD21 ' A' ' 144' ' ' LEU . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.667 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.667 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 122' ' ' LEU . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 75.93 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.92 115.93 17.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.7 mt -85.07 116.75 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.84 152.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -51.83 108.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.85 -35.34 3.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -146.56 110.69 5.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.645 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -119.48 -170.22 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.645 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.6 OUTLIER -120.55 178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 147' ' ' THR . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 134' ' ' LEU . 50.3 mm -64.3 143.33 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.99 145.08 17.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.862 0.363 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.87 157.26 31.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.06 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -74.54 -28.51 60.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m 64.31 42.35 5.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -56.59 144.96 29.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.22 72.51 1.41 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -43.42 2.67 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 p 49.93 42.63 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -62.14 146.21 51.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.75 -151.78 24.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.529 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -148.47 173.93 12.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.24 -74.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.13 157.71 7.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -85.81 -28.5 24.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.42 34.78 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -127.49 59.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.584 ' HG3' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -177.2 163.65 2.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -80.62 104.04 10.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.63 ' HG3' HG21 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 171' ' ' GLU . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.663 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 204' ' ' ILE . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' HE3' ' A' ' 167' ' ' MET . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 200' ' ' VAL . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.506 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.651 HD12 ' NE2' ' A' ' 193' ' ' GLN . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 144' ' ' LEU . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.61 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.475 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.663 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HG13 ' A' ' 128' ' ' VAL . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.692 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.623 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.623 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.552 ' CB ' HD21 ' A' ' 122' ' ' LEU . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 90.44 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.527 ' H ' HD11 ' A' ' 191' ' ' ILE . 93.5 mt-30 -142.47 102.82 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.67 116.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.58 152.55 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.33 107.95 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.06 -34.39 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.487 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -151.38 112.93 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -118.54 -169.68 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.122 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.565 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -118.87 178.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.171 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 148' ' ' ILE . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 118' ' ' GLN . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.506 HG23 ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 127' ' ' PRO . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 134' ' ' LEU . 47.2 mm -65.6 140.76 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -57.22 104.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.9 tttm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -156.89 157.28 30.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.885 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.383 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -162.71 136.91 6.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.4 p -107.03 -178.11 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 p -118.84 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -178.14 160.4 1.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.558 0.694 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.4 Cg_endo -69.64 162.75 40.8 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.677 2.252 . . . . 0.0 112.399 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 m -115.44 -44.84 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -53.53 155.97 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.12 97.39 0.74 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -175.82 122.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.359 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -174.53 163.05 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.27 159.36 9.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.3 t -67.85 -25.74 65.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 58.42 36.33 25.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.27 104.67 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -165.99 178.16 6.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -92.21 112.76 24.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 130' ' ' PRO . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.45 ' CG1' ' HB1' ' A' ' 172' ' ' ALA . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.744 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 192' ' ' GLU . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 155' ' ' VAL . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.536 HG23 ' OG1' ' A' ' 147' ' ' THR . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 143' ' ' THR . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.692 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.525 ' HB3' HD11 ' A' ' 157' ' ' ILE . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.68 ' HB2' HD21 ' A' ' 122' ' ' LEU . 45.8 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 76.82 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.05 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.39 111.26 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.29 157.0 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -50.1 107.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.85 -46.13 1.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 157.17 45.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.342 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.624 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.67 -169.97 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.624 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -122.72 -175.85 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 147' ' ' THR . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.695 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 198' ' ' VAL . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm -51.96 142.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.95 136.67 28.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -137.27 71.13 54.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.578 0.704 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 140.52 42.88 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -52.7 165.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.4 t -149.24 142.83 25.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 m -80.47 -31.7 37.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . 63.7 160.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.7 Cg_endo -69.79 101.3 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -63.99 -30.88 71.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -61.83 -47.17 86.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.36 66.1 1.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -115.11 120.0 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -97.15 158.12 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.49 110.81 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -81.89 -25.87 34.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.93 -48.7 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 55.66 56.5 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -79.25 153.13 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.708 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 163' ' ' ASN . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.598 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.802 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 194' ' ' PRO . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 192' ' ' GLU . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 146' ' ' PHE . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.512 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.546 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.653 ' HB3' HG13 ' A' ' 128' ' ' VAL . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.557 ' HA ' HD21 ' A' ' 144' ' ' LEU . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.62 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.756 ' HB2' HD21 ' A' ' 122' ' ' LEU . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -9.12 25.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -57.2 110.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.73 115.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.27 153.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.6 108.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.9 -41.54 1.6 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.43 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -139.32 125.47 20.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.609 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -121.59 -171.96 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.069 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -118.87 -176.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.741 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.708 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.598 HG22 ' OG ' ' A' ' 145' ' ' SER . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 176' ' ' LEU . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.431 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 134' ' ' LEU . 38.9 mm -78.75 143.42 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -101.88 -176.7 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.2 mttp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.869 0.366 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.21 68.03 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.57 69.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.8 103.06 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -132.05 90.29 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -96.4 126.23 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -178.03 160.45 1.25 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.698 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.8 Cg_endo -69.77 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.31 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.6 m -157.55 136.14 11.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -93.15 -63.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.3 133.1 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -125.37 -179.26 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -86.87 -72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.6 4.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 t -79.56 -26.52 41.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -52.07 153.06 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -121.51 79.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -147.66 -176.89 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.705 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -54.99 104.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.066 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 204' ' ' ILE . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.791 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 194' ' ' PRO . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 192' ' ' GLU . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.671 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.625 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.637 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.453 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.79 ' HB2' HD21 ' A' ' 122' ' ' LEU . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo -69.72 75.68 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.479 ' C ' HD11 ' A' ' 191' ' ' ILE . 66.1 mt-30 -147.48 112.06 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.664 HG12 HD12 ' A' ' 191' ' ' ILE . 25.0 mt -78.65 117.9 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.73 153.82 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.132 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.88 107.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.21 -47.0 1.04 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -140.57 152.14 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.26 -172.18 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER -126.34 -173.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.714 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 35.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.621 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.705 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.557 HG11 ' HG3' ' A' ' 127' ' ' PRO . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 134' ' ' LEU . 48.8 mm -72.54 142.96 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.43 119.1 4.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 64.48 153.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.604 0.716 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 139.19 39.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.355 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -102.94 93.77 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.7 p -76.46 112.06 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.5 m -134.85 121.5 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -80.29 160.39 68.01 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 111.078 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.4 Cg_endo -69.79 177.49 5.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -147.81 162.72 38.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.169 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -172.6 138.0 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.97 122.89 2.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -175.69 112.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.86 150.83 43.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.12 119.79 2.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -85.52 -45.81 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.887 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -99.41 50.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -88.93 115.2 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.88 -76.51 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -62.97 103.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 204' ' ' ILE . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 173' ' ' MET . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.689 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.406 HD12 ' NE2' ' A' ' 193' ' ' GLN . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 144' ' ' LEU . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 145' ' ' SER . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.645 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.428 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HB3' HG13 ' A' ' 128' ' ' VAL . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.566 ' HA ' HD21 ' A' ' 144' ' ' LEU . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.29 32.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -53.12 111.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.81 113.31 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.33 153.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -51.42 108.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.68 -44.88 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -141.72 127.63 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -119.0 -171.99 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -116.79 -176.08 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.661 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.633 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' VAL . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 134' ' ' LEU . 32.7 mm -91.34 139.58 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.49 134.46 54.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 57.52 71.62 1.06 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.613 0.721 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 177.92 5.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -100.22 152.6 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 p -114.93 174.48 5.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 p -165.0 123.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -179.27 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 53.5 Cg_endo -69.71 137.52 35.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.691 2.26 . . . . 0.0 112.383 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 m -89.3 -67.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.13 -175.14 3.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.91 170.36 31.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -149.52 135.31 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -147.74 127.06 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.61 -38.0 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 t -66.1 -42.17 89.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -115.14 144.23 43.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.7 34.65 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -93.24 -178.71 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -62.05 103.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 204' ' ' ILE . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 172' ' ' ALA . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' A' ' 157' ' ' ILE . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 194' ' ' PRO . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 193' ' ' GLN . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.656 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG23 HD12 ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 159' ' ' VAL . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.615 ' HB3' HG13 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.524 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 146' ' ' PHE . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 73.55 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.539 ' H ' HD11 ' A' ' 191' ' ' ILE . 71.3 mt-30 -125.41 114.55 18.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.17 115.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.33 153.38 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.53 108.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.77 -35.86 3.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 119.59 8.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.515 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -129.93 -175.93 3.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -115.23 178.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.126 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.728 ' O ' HG22 ' A' ' 147' ' ' THR . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.592 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 134' ' ' LEU . 48.3 mm -76.57 141.31 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 62.49 57.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -126.58 157.27 71.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.538 0.685 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 115.77 4.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -173.91 130.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.4 p -150.94 117.56 5.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -61.5 -26.35 67.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.81 73.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.586 0.708 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 79.16 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.757 2.305 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.4 m -120.22 72.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -124.92 156.45 37.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.3 42.07 1.49 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.31 65.86 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -77.63 59.85 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.15 98.33 2.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.3 m -71.97 -26.04 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -95.45 111.73 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -113.96 107.4 15.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -106.51 -173.28 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -87.86 104.18 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.699 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 129' ' ' TYR . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 167' ' ' MET . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 159' ' ' VAL . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 173' ' ' MET . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.816 ' HB3' HD13 ' A' ' 157' ' ' ILE . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 194' ' ' PRO . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' HG2' ' A' ' 192' ' ' GLU . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 153' ' ' LYS . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.881 HD11 HD12 ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 138' ' ' VAL . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 128' ' ' VAL . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.616 ' HA ' HD21 ' A' ' 144' ' ' LEU . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.881 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.694 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.791 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -9.8 27.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -51.63 119.48 4.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 99.4 mt -91.35 113.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.79 153.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.157 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -51.1 107.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -30.69 3.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -146.8 148.27 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.632 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.95 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.632 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -117.99 -174.97 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.533 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.416 HG23 ' OG1' ' A' ' 143' ' ' THR . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.492 HG21 ' HA2' ' A' ' 137' ' ' GLY . 42.8 mm -80.7 140.4 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.84 178.17 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -124.57 157.33 65.8 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 172.97 11.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.246 . . . . 0.0 112.322 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.62 92.15 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -112.25 126.26 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 60.91 29.39 18.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -119.1 160.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 0.0 111.112 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.7 Cg_endo -69.81 171.61 14.19 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -122.55 96.69 5.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -77.6 168.41 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.89 86.75 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -143.18 -177.79 5.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.77 179.07 5.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.13 141.75 3.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -78.46 -52.88 7.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 54.8 48.52 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -125.31 63.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -147.51 171.98 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -55.22 104.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.087 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 171' ' ' GLU . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE1' HD11 ' A' ' 176' ' ' LEU . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.523 HD12 ' NE2' ' A' ' 193' ' ' GLN . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 144' ' ' LEU . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.785 ' HB3' HG13 ' A' ' 128' ' ' VAL . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.439 ' HA ' HD21 ' A' ' 144' ' ' LEU . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HB2' HD21 ' A' ' 122' ' ' LEU . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 74.54 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.23 112.93 8.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.82 103.8 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 187' ' ' ASP . 8.6 p -121.86 157.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 186' ' ' VAL . 24.7 m-20 -50.4 108.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.59 -46.81 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 161.0 39.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.511 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -138.05 -169.08 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.79 -175.55 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.527 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.523 ' NE2' HD12 ' A' ' 148' ' ' ILE . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.672 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm -56.99 140.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -86.1 177.36 7.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.1 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -153.06 139.75 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.805 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 80.07 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -55.92 121.57 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.0 t -112.59 143.78 43.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.62 84.2 3.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -139.38 160.46 61.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.9 Cg_endo -69.79 -172.77 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.5 t -86.49 147.9 25.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -174.34 126.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.73 173.13 20.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -100.76 178.99 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -113.55 -29.19 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.56 89.53 1.76 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -86.02 -34.54 20.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.37 172.82 8.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.58 26.96 8.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 170.58 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -79.3 103.58 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.449 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 171' ' ' GLU . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.428 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.515 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.618 HD11 ' HB1' ' A' ' 119' ' ' ALA . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 146' ' ' PHE . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 144' ' ' LEU . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.428 ' CE ' HG12 ' A' ' 138' ' ' VAL . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.661 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.73 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.633 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.547 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.547 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.585 ' CB ' HD21 ' A' ' 122' ' ' LEU . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo -69.78 92.25 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -145.0 110.44 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.682 HG12 HD12 ' A' ' 191' ' ' ILE . 42.7 mt -85.39 113.62 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.62 149.82 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -51.69 107.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.35 -34.07 4.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -144.55 129.49 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 185' ' ' ILE . . . -138.12 -169.31 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.091 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER -119.39 -175.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm -53.02 141.89 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.75 158.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.65 157.29 77.58 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.622 0.725 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.14 28.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -110.96 121.93 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -123.25 137.13 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 t -131.13 -56.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -179.2 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 53.4 Cg_endo -69.77 164.98 32.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.2 m 57.68 37.07 27.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -89.93 63.68 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.18 81.98 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -109.58 82.01 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.73 159.02 21.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.11 57.89 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -79.41 -26.41 41.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -153.22 143.38 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -91.96 100.94 13.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -88.31 148.45 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -84.98 103.58 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 171' ' ' GLU . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 204' ' ' ILE . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 172' ' ' ALA . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.736 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 197' ' ' THR . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 194' ' ' PRO . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 119' ' ' ALA . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 146' ' ' PHE . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.736 HG22 ' HG ' ' A' ' 144' ' ' LEU . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.673 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.554 ' HB3' HG13 ' A' ' 128' ' ' VAL . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.734 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.649 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 122' ' ' LEU . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -9.12 25.32 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -52.03 119.53 4.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.43 103.78 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.7 155.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -50.63 107.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.65 -56.81 0.71 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.47 157.63 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.526 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.84 -168.83 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.098 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -113.95 -174.92 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 191' ' ' ILE . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 145' ' ' SER . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 198' ' ' VAL . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.42 HG12 ' HG3' ' A' ' 139' ' ' GLU . 48.7 mm -50.79 144.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.97 -174.72 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -132.04 160.6 67.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 109.52 2.34 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.366 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -91.5 -64.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -72.99 140.59 47.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -166.57 128.64 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -133.7 160.44 68.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.572 0.701 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.6 Cg_endo -69.8 -32.99 17.34 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -139.36 -179.77 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.45 -57.39 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.93 64.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.441 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.07 116.95 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -138.75 152.48 47.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.22 53.23 5.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -82.39 -49.7 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -153.51 -178.2 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -109.5 90.25 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HB2' HG23 ' A' ' 198' ' ' VAL . 12.5 pt20 -79.21 155.58 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -89.25 103.78 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 182' ' ' GLN . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.667 ' CE1' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.667 HD23 ' CE1' ' A' ' 129' ' ' TYR . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 172' ' ' ALA . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 159' ' ' VAL . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 HG12 ' A' ' 142' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 155' ' ' VAL . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 153' ' ' LYS . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.786 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.581 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.554 ' HB2' HD21 ' A' ' 122' ' ' LEU . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 76.7 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -142.78 116.16 9.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.82 105.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.27 155.84 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -50.6 107.84 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.78 -46.17 1.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -139.03 152.99 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -135.81 -176.37 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.83 -175.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.523 ' H ' HG22 ' A' ' 191' ' ' ILE . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 45.4 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.529 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 118' ' ' GLN . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 127' ' ' PRO . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 134' ' ' LEU . 34.5 mm -116.44 139.17 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.6 138.69 45.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.0 pttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -166.24 68.35 1.09 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 177.17 5.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.06 120.5 35.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -117.17 110.95 18.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -144.55 115.22 7.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -167.06 160.44 10.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.75 159.93 51.6 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 m -138.39 122.45 17.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -128.52 -57.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.94 -178.1 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -151.68 111.2 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -122.28 96.13 4.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.22 60.93 0.15 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 t -85.19 -32.61 22.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -121.88 163.37 19.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -81.57 101.21 9.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 198' ' ' VAL . 5.3 pt20 -132.18 155.3 48.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . . . -85.19 103.92 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 123' ' ' TYR . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.433 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.763 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 202' ' ' PHE . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 199' ' ' THR . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.7 ' HB3' HD13 ' A' ' 157' ' ' ILE . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 193' ' ' GLN . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG22 ' HG ' ' A' ' 144' ' ' LEU . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.62 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.52 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.632 ' HB3' HG13 ' A' ' 128' ' ' VAL . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.442 ' HA ' HD21 ' A' ' 144' ' ' LEU . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.499 HD21 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 122' ' ' LEU . 1.7 tp-100 -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.77 21.89 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -59.11 111.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.0 mt -78.62 115.56 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.39 154.46 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.135 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -51.07 108.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.56 -53.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -136.17 128.44 30.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -116.56 -169.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -117.32 -175.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 148' ' ' ILE . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.592 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 7.0 tp-100 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 118' ' ' GLN . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.49 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.763 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 142' ' ' VAL . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.37 143.4 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.02 115.62 2.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -117.6 160.61 37.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.74 40.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -94.39 135.72 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -102.29 158.83 15.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 p -153.32 166.64 31.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.33 70.44 1.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.516 0.674 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.45 45.07 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.647 2.231 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.5 m -63.37 157.54 22.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.7 163.22 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.97 126.02 4.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.59 148.85 29.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -155.05 151.32 28.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.78 106.01 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 p -82.69 -54.13 5.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -73.64 165.77 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -115.88 34.45 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.416 ' CD ' HG23 ' A' ' 198' ' ' VAL . 10.3 pt20 -90.18 -172.19 3.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.717 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . -87.54 103.32 15.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.745 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.68 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.732 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 204' ' ' ILE . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' CG1' ' HE2' ' A' ' 167' ' ' MET . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 199' ' ' THR . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.556 ' HB3' HD13 ' A' ' 157' ' ' ILE . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.514 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 192' ' ' GLU . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.628 ' HG2' HG13 ' A' ' 155' ' ' VAL . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.628 HG13 ' HG2' ' A' ' 153' ' ' LYS . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.626 HD11 HD12 ' A' ' 176' ' ' LEU . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.594 ' O ' ' ND2' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.732 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 163' ' ' ASN . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.689 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.592 ' HB2' HD21 ' A' ' 122' ' ' LEU . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 71.58 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -133.99 113.59 12.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.63 116.95 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.45 153.45 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.55 107.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.8 -33.38 4.45 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -145.13 133.71 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.61 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -127.54 -169.59 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.61 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -122.93 -173.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 2.2 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 147' ' ' THR . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.717 HE21 ' HB2' ' A' ' 119' ' ' ALA . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 176' ' ' LEU . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.745 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 134' ' ' LEU . 49.3 mm -85.66 142.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.84 107.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -127.21 162.54 47.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -177.38 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -151.83 -45.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m -147.09 148.52 31.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.9 m -128.69 175.63 8.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.76 73.25 0.42 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.697 . . . . 0.0 111.041 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.65 2.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.659 2.239 . . . . 0.0 112.326 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.2 t -164.01 162.65 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -147.62 175.28 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.17 161.53 34.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -145.85 158.78 43.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -174.12 138.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 24.23 21.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.0 t -65.12 -28.34 69.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.35 -171.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -80.69 -2.54 47.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 63.81 38.02 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -111.34 103.52 11.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.058 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 171' ' ' GLU . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 144' ' ' LEU . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.805 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.685 ' HB3' HD13 ' A' ' 157' ' ' ILE . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 194' ' ' PRO . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 191' ' ' ILE . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 146' ' ' PHE . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.805 HG22 ' HG ' ' A' ' 144' ' ' LEU . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.94 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.447 ' C ' HD11 ' A' ' 191' ' ' ILE . 46.7 mt-30 -130.94 117.49 19.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 81.0 mt -85.78 114.42 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.77 152.32 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.5 107.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.63 -30.92 5.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -147.61 131.42 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -128.22 -168.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -113.77 -176.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.573 ' HB2' HE21 ' A' ' 196' ' ' GLN . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.797 ' O ' HG22 ' A' ' 147' ' ' THR . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.573 HE21 ' HB2' ' A' ' 193' ' ' GLN . 98.1 mm-40 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' A' ' 127' ' ' PRO . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm -62.95 142.94 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.64 114.12 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.357 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -117.5 68.97 5.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 127.69 14.96 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -65.59 139.78 58.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -110.73 133.31 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.3 t -128.77 95.86 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -64.15 160.38 49.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.594 0.711 . . . . 0.0 111.142 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.67 166.83 26.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 0.0 112.361 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.7 p -70.46 -62.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -165.27 159.86 17.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.3 88.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -173.0 110.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -132.44 88.89 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.03 154.9 7.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.4 m -79.94 -46.92 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 59.59 44.22 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -98.5 67.88 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -140.58 175.47 9.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -54.43 103.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.499 ' O ' HD23 ' A' ' 134' ' ' LEU . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.578 ' HB1' ' HE1' ' A' ' 168' ' ' PHE . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 204' ' ' ILE . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 138' ' ' VAL . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 202' ' ' PHE . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.753 HD12 HG13 ' A' ' 159' ' ' VAL . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 157' ' ' ILE . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.556 ' HG2' HG13 ' A' ' 155' ' ' VAL . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.556 HG13 ' HG2' ' A' ' 153' ' ' LYS . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 146' ' ' PHE . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.753 HG13 HD12 ' A' ' 144' ' ' LEU . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.578 ' HE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.609 ' HA ' HD21 ' A' ' 144' ' ' LEU . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HB2' HD21 ' A' ' 122' ' ' LEU . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 76.32 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.445 ' C ' HD11 ' A' ' 191' ' ' ILE . 84.1 mt-30 -134.2 112.44 11.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.84 115.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.66 152.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -51.07 107.28 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.86 5.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.64 126.92 21.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.554 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -125.15 -167.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.554 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -118.86 -174.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.449 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.55 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.498 HG11 ' CD2' ' A' ' 176' ' ' LEU . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 127' ' ' PRO . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.433 ' CE1' HG21 ' A' ' 142' ' ' VAL . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 134' ' ' LEU . 30.0 mm -67.15 137.17 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.35 161.37 11.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.99 159.22 31.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -178.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 0.0 112.337 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -154.05 96.9 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -134.33 123.47 24.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -155.44 177.45 11.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -137.28 160.48 65.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.575 0.703 . . . . 0.0 111.095 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.9 Cg_endo -69.76 170.06 17.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 2.267 . . . . 0.0 112.311 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 p -110.79 161.58 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.2 -73.88 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.14 150.93 23.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -151.78 144.85 24.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -126.25 156.7 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.76 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 t -77.15 -55.73 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -153.34 118.81 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.54 25.11 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -153.0 174.47 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.587 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -65.97 103.73 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' HG21 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 171' ' ' GLU . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.652 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.699 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.402 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.76 HG11 ' CB ' ' A' ' 172' ' ' ALA . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 199' ' ' THR . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 142' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.564 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 157' ' ' ILE . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 155' ' ' VAL . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 153' ' ' LYS . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 133' ' ' ALA . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.699 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.853 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.76 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.604 ' HA ' HD21 ' A' ' 144' ' ' LEU . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 157' ' ' ILE . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.463 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.619 ' HB2' HD21 ' A' ' 122' ' ' LEU . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.2 22.99 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -51.71 106.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.0 mt -78.95 108.55 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 187' ' ' ASP . 9.3 p -126.24 157.64 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.409 ' N ' HG22 ' A' ' 186' ' ' VAL . 1.9 p-10 -50.57 131.57 25.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.88 -47.87 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -148.23 143.29 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -128.03 -168.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.71 -175.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.587 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.564 HG22 ' OG ' ' A' ' 145' ' ' SER . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 143' ' ' THR . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.416 HG21 ' HD3' ' A' ' 127' ' ' PRO . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 134' ' ' LEU . 17.7 mm -70.02 140.82 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.25 171.98 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 pttm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -136.24 160.57 66.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -173.03 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -153.49 117.69 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -165.04 153.57 12.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -157.48 135.81 11.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.1 73.82 37.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.61 0.719 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 174.97 8.76 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.66 2.24 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.0 t -152.89 140.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -146.49 169.62 18.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.73 137.57 8.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.68 124.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -155.15 167.67 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.58 135.88 2.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.5 p -85.32 -32.93 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.96 55.65 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -143.3 41.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -144.36 157.83 44.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -68.99 103.78 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.574 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 194' ' ' PRO . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 119' ' ' ALA . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 176' ' ' LEU . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.617 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.644 ' HA ' HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.569 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.85 24.64 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -51.88 119.49 4.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.4 mt -92.75 122.04 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.5 153.34 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -51.74 108.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.59 -27.34 4.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -153.92 149.61 27.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.551 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.6 -169.78 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.551 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -115.38 -174.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.534 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 176' ' ' LEU . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.09 143.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.33 107.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 61.34 71.07 0.82 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.29 2.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -115.98 170.31 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -145.08 136.72 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.43 73.8 8.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -177.6 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.2 p -130.76 178.89 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -142.08 151.59 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.49 -114.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.88 39.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -63.6 -68.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.89 145.02 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.89 -55.59 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -91.59 120.27 32.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -136.12 -76.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -131.32 -174.32 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -55.56 103.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 204' ' ' ILE . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 172' ' ' ALA . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 194' ' ' PRO . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.56 ' HG3' HG13 ' A' ' 155' ' ' VAL . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 153' ' ' LYS . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.771 HG22 ' HG ' ' A' ' 144' ' ' LEU . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.454 ' HB3' HG13 ' A' ' 128' ' ' VAL . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.522 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' A' ' 157' ' ' ILE . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.728 ' HB2' HD21 ' A' ' 122' ' ' LEU . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -8.42 23.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -58.11 111.64 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.8 mt -81.52 113.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.31 154.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.41 108.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.08 -50.92 0.87 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -133.91 128.09 33.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.586 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -118.63 -169.99 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -117.99 -175.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.171 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.756 ' O ' HG22 ' A' ' 147' ' ' THR . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.46 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 134' ' ' LEU . 50.6 mm -75.09 142.25 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.21 158.54 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.786 0.327 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 171' ' ' GLU . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.771 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.476 HG12 ' HE2' ' A' ' 167' ' ' MET . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 172' ' ' ALA . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.608 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.691 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 194' ' ' PRO . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 193' ' ' GLN . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.548 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 ' HG ' ' A' ' 144' ' ' LEU . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.476 ' HE2' HG12 ' A' ' 138' ' ' VAL . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.771 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.799 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.685 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.585 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 148' ' ' ILE . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 147' ' ' THR . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.557 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 34.1 tp60 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.438 ' N ' HE21 ' A' ' 196' ' ' GLN . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' VAL . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.608 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 134' ' ' LEU . 45.5 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.828 0.347 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.706 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 204' ' ' ILE . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.461 HG13 ' HB1' ' A' ' 172' ' ' ALA . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 194' ' ' PRO . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.64 HD11 ' HB1' ' A' ' 119' ' ' ALA . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.675 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.756 ' HB3' HG13 ' A' ' 128' ' ' VAL . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.601 ' HA ' HD21 ' A' ' 144' ' ' LEU . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.667 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.667 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 122' ' ' LEU . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.789 0.328 . . . . 0.0 111.091 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 147' ' ' THR . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 134' ' ' LEU . 50.3 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.63 ' HG3' HG21 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 171' ' ' GLU . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.663 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 204' ' ' ILE . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' HE3' ' A' ' 167' ' ' MET . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 200' ' ' VAL . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.506 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.651 HD12 ' NE2' ' A' ' 193' ' ' GLN . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 144' ' ' LEU . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.61 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.475 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.663 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HG13 ' A' ' 128' ' ' VAL . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.692 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.623 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.623 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.552 ' CB ' HD21 ' A' ' 122' ' ' LEU . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.75 0.309 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 148' ' ' ILE . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.506 HG23 ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 127' ' ' PRO . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 134' ' ' LEU . 47.2 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.812 0.339 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 130' ' ' PRO . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.45 ' CG1' ' HB1' ' A' ' 172' ' ' ALA . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.744 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 192' ' ' GLU . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 155' ' ' VAL . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.536 HG23 ' OG1' ' A' ' 147' ' ' THR . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 143' ' ' THR . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.692 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.525 ' HB3' HD11 ' A' ' 157' ' ' ILE . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.68 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.0 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 147' ' ' THR . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.695 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 198' ' ' VAL . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.708 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 163' ' ' ASN . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.598 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.802 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 194' ' ' PRO . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 192' ' ' GLU . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 146' ' ' PHE . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.512 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.546 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.653 ' HB3' HG13 ' A' ' 128' ' ' VAL . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.557 ' HA ' HD21 ' A' ' 144' ' ' LEU . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.62 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.756 ' HB2' HD21 ' A' ' 122' ' ' LEU . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.741 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.708 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.598 HG22 ' OG ' ' A' ' 145' ' ' SER . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 176' ' ' LEU . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.431 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 134' ' ' LEU . 38.9 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.705 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.756 0.312 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 204' ' ' ILE . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.791 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 194' ' ' PRO . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 192' ' ' GLU . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.671 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.625 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.637 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.453 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.79 ' HB2' HD21 ' A' ' 122' ' ' LEU . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.76 0.314 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.714 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 6.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.621 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.705 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.557 HG11 ' HG3' ' A' ' 127' ' ' PRO . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 134' ' ' LEU . 48.8 mm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.766 0.317 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 204' ' ' ILE . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 173' ' ' MET . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.689 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.406 HD12 ' NE2' ' A' ' 193' ' ' GLN . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 144' ' ' LEU . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 145' ' ' SER . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.645 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.428 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HB3' HG13 ' A' ' 128' ' ' VAL . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.566 ' HA ' HD21 ' A' ' 144' ' ' LEU . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.773 0.321 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.661 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.633 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' VAL . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 134' ' ' LEU . 32.7 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 204' ' ' ILE . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 172' ' ' ALA . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' A' ' 157' ' ' ILE . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 194' ' ' PRO . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 193' ' ' GLN . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.656 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.582 HG23 HD12 ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 159' ' ' VAL . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.615 ' HB3' HG13 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.524 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 146' ' ' PHE . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 1.6 tt0 -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.728 ' O ' HG22 ' A' ' 147' ' ' THR . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.592 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 134' ' ' LEU . 48.3 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.752 0.31 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.699 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 129' ' ' TYR . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 167' ' ' MET . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 159' ' ' VAL . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 173' ' ' MET . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.816 ' HB3' HD13 ' A' ' 157' ' ' ILE . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 194' ' ' PRO . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' HG2' ' A' ' 192' ' ' GLU . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 153' ' ' LYS . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.881 HD11 HD12 ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 138' ' ' VAL . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 128' ' ' VAL . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.616 ' HA ' HD21 ' A' ' 144' ' ' LEU . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.881 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.694 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.791 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.321 . . . . 0.0 111.153 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.533 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.416 HG23 ' OG1' ' A' ' 143' ' ' THR . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.492 HG21 ' HA2' ' A' ' 137' ' ' GLY . 42.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.773 0.32 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 171' ' ' GLU . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE1' HD11 ' A' ' 176' ' ' LEU . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.523 HD12 ' NE2' ' A' ' 193' ' ' GLN . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 144' ' ' LEU . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.785 ' HB3' HG13 ' A' ' 128' ' ' VAL . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.439 ' HA ' HD21 ' A' ' 144' ' ' LEU . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HB2' HD21 ' A' ' 122' ' ' LEU . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.349 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.527 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.523 ' NE2' HD12 ' A' ' 148' ' ' ILE . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.672 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.449 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 171' ' ' GLU . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.428 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.515 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.618 HD11 ' HB1' ' A' ' 119' ' ' ALA . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 146' ' ' PHE . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 144' ' ' LEU . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.428 ' CE ' HG12 ' A' ' 138' ' ' VAL . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.661 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.73 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.633 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.547 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.547 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.585 ' CB ' HD21 ' A' ' 122' ' ' LEU . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.8 0.334 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.762 0.315 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 171' ' ' GLU . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 204' ' ' ILE . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 172' ' ' ALA . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.736 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 197' ' ' THR . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 194' ' ' PRO . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 119' ' ' ALA . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 146' ' ' PHE . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.736 HG22 ' HG ' ' A' ' 144' ' ' LEU . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.673 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.554 ' HB3' HG13 ' A' ' 128' ' ' VAL . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.734 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.649 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 122' ' ' LEU . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.778 0.323 . . . . 0.0 111.122 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 191' ' ' ILE . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 145' ' ' SER . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 198' ' ' VAL . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.42 HG12 ' HG3' ' A' ' 139' ' ' GLU . 48.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 182' ' ' GLN . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.667 ' CE1' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.667 HD23 ' CE1' ' A' ' 129' ' ' TYR . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 172' ' ' ALA . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 159' ' ' VAL . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 HG12 ' A' ' 142' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 155' ' ' VAL . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 153' ' ' LYS . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.786 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.581 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.554 ' HB2' HD21 ' A' ' 122' ' ' LEU . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.793 0.33 . . . . 0.0 111.123 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.523 ' H ' HG22 ' A' ' 191' ' ' ILE . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.532 ' NE2' HE21 ' A' ' 196' ' ' GLN . 9.2 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.532 HE21 ' NE2' ' A' ' 193' ' ' GLN . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 127' ' ' PRO . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 134' ' ' LEU . 34.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.804 0.335 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 123' ' ' TYR . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.433 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.763 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 202' ' ' PHE . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 199' ' ' THR . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.7 ' HB3' HD13 ' A' ' 157' ' ' ILE . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 193' ' ' GLN . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG22 ' HG ' ' A' ' 144' ' ' LEU . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.62 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.52 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.632 ' HB3' HG13 ' A' ' 128' ' ' VAL . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.442 ' HA ' HD21 ' A' ' 144' ' ' LEU . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.499 HD21 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.832 0.348 . . . . 0.0 111.123 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 148' ' ' ILE . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.592 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 20.9 tp60 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 176' ' ' LEU . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.49 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.763 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 142' ' ' VAL . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.717 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.745 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.68 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.732 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 204' ' ' ILE . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' CG1' ' HE2' ' A' ' 167' ' ' MET . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 199' ' ' THR . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.556 ' HB3' HD13 ' A' ' 157' ' ' ILE . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.743 HD12 HE21 ' A' ' 193' ' ' GLN . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 192' ' ' GLU . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.628 ' HG2' HG13 ' A' ' 155' ' ' VAL . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.628 HG13 ' HG2' ' A' ' 153' ' ' LYS . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.626 HD11 HD12 ' A' ' 176' ' ' LEU . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.712 HD21 ' N ' ' A' ' 166' ' ' ARG . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.712 ' N ' HD21 ' A' ' 163' ' ' ASN . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.732 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.689 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.592 ' HB2' HD21 ' A' ' 122' ' ' LEU . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 0.0 111.155 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.743 HE21 HD12 ' A' ' 148' ' ' ILE . 8.1 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 147' ' ' THR . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.717 HE21 ' HB2' ' A' ' 119' ' ' ALA . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 176' ' ' LEU . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.745 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 134' ' ' LEU . 49.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.76 0.314 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 171' ' ' GLU . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 144' ' ' LEU . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.805 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.685 ' HB3' HD13 ' A' ' 157' ' ' ILE . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 194' ' ' PRO . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 191' ' ' ILE . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 146' ' ' PHE . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.805 HG22 ' HG ' ' A' ' 144' ' ' LEU . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.764 0.316 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.797 ' O ' HG22 ' A' ' 147' ' ' THR . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.692 HE21 ' HB2' ' A' ' 119' ' ' ALA . 30.7 mm100 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' A' ' 127' ' ' PRO . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.709 0.29 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.499 ' O ' HD23 ' A' ' 134' ' ' LEU . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.578 ' HB1' ' HE1' ' A' ' 168' ' ' PHE . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 204' ' ' ILE . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 138' ' ' VAL . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 202' ' ' PHE . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.753 HD12 HG13 ' A' ' 159' ' ' VAL . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 157' ' ' ILE . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.556 ' HG2' HG13 ' A' ' 155' ' ' VAL . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.556 HG13 ' HG2' ' A' ' 153' ' ' LYS . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 146' ' ' PHE . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.753 HG13 HD12 ' A' ' 144' ' ' LEU . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.578 ' HE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.609 ' HA ' HD21 ' A' ' 144' ' ' LEU . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HB2' HD21 ' A' ' 122' ' ' LEU . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.449 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.55 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.498 HG11 ' CD2' ' A' ' 176' ' ' LEU . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 127' ' ' PRO . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.433 ' CE1' HG21 ' A' ' 142' ' ' VAL . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 134' ' ' LEU . 30.0 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.587 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.739 0.304 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' HG21 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 171' ' ' GLU . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.652 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.699 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.402 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.76 HG11 ' CB ' ' A' ' 172' ' ' ALA . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 199' ' ' THR . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 142' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.564 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 157' ' ' ILE . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 155' ' ' VAL . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 153' ' ' LYS . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 133' ' ' ALA . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.699 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.853 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.76 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.604 ' HA ' HD21 ' A' ' 144' ' ' LEU . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 157' ' ' ILE . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.463 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.619 ' HB2' HD21 ' A' ' 122' ' ' LEU . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.792 0.329 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.587 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.564 HG22 ' OG ' ' A' ' 145' ' ' SER . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 143' ' ' THR . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.416 HG21 ' HD3' ' A' ' 127' ' ' PRO . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 134' ' ' LEU . 17.7 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.819 0.343 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.574 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 194' ' ' PRO . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 119' ' ' ALA . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 176' ' ' LEU . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.617 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.644 ' HA ' HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.569 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.817 0.341 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.534 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 176' ' ' LEU . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 204' ' ' ILE . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 172' ' ' ALA . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 194' ' ' PRO . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.56 ' HG3' HG13 ' A' ' 155' ' ' VAL . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 153' ' ' LYS . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.771 HG22 ' HG ' ' A' ' 144' ' ' LEU . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.454 ' HB3' HG13 ' A' ' 128' ' ' VAL . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.522 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' A' ' 157' ' ' ILE . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.728 ' HB2' HD21 ' A' ' 122' ' ' LEU . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.768 0.318 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.436 ' NE2' HE21 ' A' ' 196' ' ' GLN . 8.2 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.756 ' O ' HG22 ' A' ' 147' ' ' THR . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.46 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 134' ' ' LEU . 50.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -121.02 69.73 18.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.605 0.717 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.76 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.659 2.239 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -63.74 152.8 38.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 114.42 3.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -169.97 166.65 9.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -147.24 160.4 39.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.52 0.676 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.79 168.19 22.3 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.1 p -104.85 -71.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -123.83 -179.16 4.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.12 141.46 15.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.58 161.02 33.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.366 . . . . 0.0 110.878 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -163.56 153.25 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.24 95.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.9 p -79.53 -41.25 27.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -54.39 146.68 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -89.95 100.12 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -127.4 171.71 11.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -92.67 107.83 19.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.083 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.7 ptm -109.62 135.09 20.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.612 0.72 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -165.39 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -109.99 -0.8 17.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -118.45 -22.11 7.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.961 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -131.96 86.4 2.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.93 -13.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.093 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.7 pt-20 -151.33 162.52 26.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.645 0.736 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 53.4 Cg_endo -69.77 148.22 64.52 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 171' ' ' GLU . 5.8 p -72.76 113.46 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 137.35 80.94 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.701 0.762 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.74 -165.2 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.296 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 m -118.58 -48.2 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -74.71 -55.32 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.771 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.14 -27.75 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.9 tp -69.41 -37.63 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.87 -14.79 38.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 142.26 -12.67 2.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.476 HG12 ' HE2' ' A' ' 167' ' ' MET . 3.4 p -87.97 149.44 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.729 0.299 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -121.91 78.22 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.0 -132.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -169.6 164.87 10.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.873 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 172' ' ' ALA . 15.3 m -130.27 115.9 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.608 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.4 m -124.28 105.83 9.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.691 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.2 mp -116.41 131.23 57.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -106.35 103.07 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.8 p90 -126.6 163.81 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 194' ' ' PRO . 42.9 p -112.27 130.85 55.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 193' ' ' GLN . 31.8 mt -94.33 102.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -56.29 146.55 23.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.7 m -52.32 -24.07 6.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -88.83 23.16 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.52 48.96 83.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.548 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.7 ttpt -124.98 118.51 26.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 107.09 18.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.548 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.4 m -131.4 -174.05 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.15 29.65 16.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 24.0 mm -51.58 102.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -132.73 114.72 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 ' HG ' ' A' ' 144' ' ' LEU . 15.9 t -78.07 137.65 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -107.8 -32.22 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.105 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -167.24 151.73 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.92 -159.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.083 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -45.59 165.51 0.17 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.638 0.732 . . . . 0.0 110.87 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.75 -7.84 22.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.635 2.224 . . . . 0.0 112.375 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -175.51 158.1 2.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 165' ' ' LYS . 56.5 mtt85 -35.26 100.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.476 ' HE2' HG12 ' A' ' 138' ' ' VAL . 54.6 mmm -144.81 -77.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.771 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -108.96 3.36 22.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -67.12 -43.9 81.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -56.36 -60.37 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.799 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -54.8 -41.9 71.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.633 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -63.14 -37.08 85.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.685 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -71.66 -54.4 10.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -61.77 -30.81 71.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -64.62 -54.44 31.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.15 -31.83 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -79.08 -62.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -53.05 -27.95 22.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -51.72 157.81 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -131.64 120.71 23.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.28 134.93 54.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.585 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -103.58 136.28 19.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.623 0.725 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 76.56 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.676 2.251 . . . . 0.0 112.362 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -128.83 110.33 12.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.25 112.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.11 154.13 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.81 107.85 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.72 -63.11 0.52 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -119.29 108.49 14.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -110.94 -169.77 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.5 OUTLIER -114.04 179.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 65.74 81.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 148' ' ' ILE . 9.0 pt20 -152.22 93.94 3.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.916 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 147' ' ' THR . 54.0 Cg_endo -69.78 -8.09 22.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.87 60.69 0.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.557 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 34.1 tp60 -105.27 126.29 51.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.438 ' N ' HE21 ' A' ' 196' ' ' GLN . 20.8 p -128.81 142.43 50.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' VAL . 2.9 p -120.6 110.59 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.608 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -121.15 118.05 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.8 135.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -77.48 135.46 38.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.59 106.22 18.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -98.67 127.14 44.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 134' ' ' LEU . 45.5 mm -62.81 142.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -52.13 151.95 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.6 mttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -114.83 72.82 2.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.571 0.701 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 165.82 29.6 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -118.62 155.43 30.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 t -153.34 112.92 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.133 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -103.26 76.66 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.1 73.21 12.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.555 0.693 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 138.73 38.44 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.9 p -115.0 160.05 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -170.09 118.8 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.2 129.31 5.82 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -169.68 119.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -175.62 168.29 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.88 110.15 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.518 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 t -84.27 -48.91 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.67 56.59 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 71.56 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -171.71 145.6 2.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -54.9 103.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.5 mtm -120.45 147.49 45.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.589 0.709 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -165.61 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -118.66 -3.01 10.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -115.09 -16.84 11.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.41 81.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.12 -33.11 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.77 158.32 75.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.706 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.75 145.2 56.49 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.1 p -66.53 135.92 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.171 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.14 141.4 22.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 0.0 110.933 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.36 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 0.0 112.32 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t -118.82 -35.69 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -87.52 -58.71 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.2 -27.52 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 204' ' ' ILE . 13.1 tp -66.95 -42.34 85.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -90.05 -3.64 57.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -57.13 -70.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.65 -5.23 3.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 p -95.66 147.48 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -120.83 78.58 1.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.71 -136.66 0.94 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.93 170.95 20.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.461 HG13 ' HB1' ' A' ' 172' ' ' ALA . 17.9 t -135.73 112.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.87 106.74 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.8 mp -119.29 135.35 54.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.39 109.74 21.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.8 p90 -130.17 166.07 21.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 194' ' ' PRO . 65.0 p -111.95 145.32 39.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.64 HD11 ' HB1' ' A' ' 119' ' ' ALA . 26.8 mt -110.15 102.76 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.11 147.05 40.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.4 m -52.04 -24.16 6.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.2 p -87.83 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.87 49.02 83.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.517 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -122.64 143.12 49.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.767 0.317 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.9 113.77 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.5 178.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 t70 64.0 41.65 6.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -60.53 97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -119.85 113.79 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 42.5 t -80.39 133.09 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.84 -33.83 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -179.66 139.44 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.07 125.24 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.61 165.29 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -13.0 34.06 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -177.21 -172.85 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -52.34 97.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 75.3 mmm -142.32 -74.87 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.675 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -108.54 5.78 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -59.78 -35.0 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -71.11 -50.41 33.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.756 ' HB3' HG13 ' A' ' 128' ' ' VAL . 11.5 mm-40 -61.26 -33.03 72.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -73.24 -43.84 60.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.601 ' HA ' HD21 ' A' ' 144' ' ' LEU . 25.7 ttp -68.33 -51.1 48.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -60.89 -30.93 70.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.16 -58.16 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.667 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.4 -34.27 47.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -78.73 -37.82 40.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -86.22 7.41 25.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.95 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.667 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -84.01 165.01 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 123.18 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.51 132.35 56.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 122' ' ' LEU . 6.5 tp60 -99.14 136.18 20.59 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 75.93 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.648 2.232 . . . . 0.0 112.376 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.92 115.93 17.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.7 mt -85.07 116.75 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.84 152.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -51.83 108.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.85 -35.34 3.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -146.56 110.69 5.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.645 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -119.48 -170.22 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.645 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.6 OUTLIER -120.55 178.93 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 65.29 59.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -145.55 97.55 4.65 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 147' ' ' THR . 54.6 Cg_endo -69.65 -6.78 19.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.668 2.245 . . . . 0.0 112.382 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.0 80.79 0.28 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.49 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 57.6 mm-40 -124.56 128.65 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.3 p -130.32 135.39 48.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.21 110.52 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.5 116.82 30.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.706 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.7 p -138.18 124.01 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 133.5 42.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.99 105.87 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -101.8 126.87 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 134' ' ' LEU . 50.3 mm -64.3 143.33 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.99 145.08 17.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.862 0.363 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.87 157.26 31.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.571 0.701 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.06 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.652 2.235 . . . . 0.0 112.363 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -74.54 -28.51 60.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m 64.31 42.35 5.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -56.59 144.96 29.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.22 72.51 1.41 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -43.42 2.67 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.359 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.4 p 49.93 42.63 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -62.14 146.21 51.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.75 -151.78 24.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.529 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -148.47 173.93 12.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.24 -74.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.13 157.71 7.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -85.81 -28.5 24.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.832 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.42 34.78 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -127.49 59.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.584 ' HG3' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -177.2 163.65 2.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -80.62 104.04 10.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.3 ptp -114.14 145.46 33.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.2 Cg_endo -69.8 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.731 2.287 . . . . 0.0 112.338 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.5 5.82 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -120.68 -30.02 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.52 81.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.53 131.68 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 62.57 159.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.724 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.63 ' HG3' HG21 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.71 146.33 60.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.315 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 171' ' ' GLU . 14.2 p -73.81 130.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.88 137.05 54.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.2 Cg_endo -69.81 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.29 -33.75 5.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -87.14 -56.06 3.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.663 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -54.04 -27.03 29.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.129 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 204' ' ' ILE . 7.6 tp -64.99 -35.55 81.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -97.92 -10.85 23.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' HE3' ' A' ' 167' ' ' MET . 0.0 OUTLIER -51.51 -75.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 138.48 -5.95 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.472 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -95.78 147.0 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -117.33 72.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.87 -149.87 1.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.83 168.79 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 200' ' ' VAL . 39.1 t -131.82 111.47 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.506 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -123.0 106.11 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 159' ' ' VAL . 9.4 mp -117.1 131.53 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 82.0 p -105.67 101.72 11.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.1 p90 -125.2 162.63 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.3 p -112.65 140.07 47.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.651 HD12 ' NE2' ' A' ' 193' ' ' GLN . 36.9 mt -103.8 102.69 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -58.42 146.36 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.4 m -52.46 -23.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 p -88.18 22.85 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 50.02 72.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -125.23 144.81 50.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.23 115.12 28.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.111 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.34 178.01 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.7 t0 63.8 38.64 8.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 146' ' ' PHE . 20.8 mm -60.13 99.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -125.14 115.3 20.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 144' ' ' LEU . 57.8 t -79.25 125.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.96 -37.35 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.35 137.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.57 132.03 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 2.8 p30 56.89 162.73 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.929 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.61 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.79 -50.81 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 0.0 112.331 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 166' ' ' ARG . 11.6 tptp -154.62 89.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 165' ' ' LYS . 0.5 OUTLIER 51.08 107.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.475 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 87.1 mmm -153.5 -50.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.663 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -138.0 8.79 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -61.09 -40.76 94.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -61.33 -60.89 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HG13 ' A' ' 128' ' ' VAL . 61.0 mm-40 -55.02 -32.42 61.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -71.53 -53.59 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.692 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.9 ttt -59.54 -52.9 63.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -58.93 -30.71 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -67.38 -58.31 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.623 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -50.72 -28.84 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -77.47 -62.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -19.52 40.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.623 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 19.3 m0 -57.67 163.58 2.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.55 126.92 19.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -117.01 138.4 51.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.552 ' CB ' HD21 ' A' ' 122' ' ' LEU . 54.9 tt0 -106.25 137.24 19.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.538 0.685 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 90.44 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.643 2.228 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.527 ' H ' HD11 ' A' ' 191' ' ' ILE . 93.5 mt-30 -142.47 102.82 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.67 116.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.58 152.55 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -51.33 107.95 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.06 -34.39 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.487 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -151.38 112.93 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -118.54 -169.68 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.122 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.565 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -118.87 178.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.171 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.3 mt-10 68.06 74.49 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 148' ' ' ILE . 4.8 pt20 -145.98 91.67 5.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.712 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.78 -7.68 21.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -120.94 53.26 0.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.5 131.64 36.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.896 0.379 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.7 p -137.15 132.91 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 118' ' ' GLN . 3.0 p -120.62 110.54 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.506 HG23 ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -114.42 119.06 35.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 127' ' ' PRO . 14.0 m -126.95 154.8 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.67 105.63 15.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -71.52 118.51 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -114.86 127.39 55.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 134' ' ' LEU . 47.2 mm -65.6 140.76 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -57.22 104.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.9 tttm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.0 t0 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -156.89 157.28 30.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.885 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.383 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -162.71 136.91 6.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.4 p -107.03 -178.11 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 p -118.84 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -178.14 160.4 1.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.558 0.694 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.4 Cg_endo -69.64 162.75 40.8 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.677 2.252 . . . . 0.0 112.399 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 m -115.44 -44.84 2.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -53.53 155.97 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.12 97.39 0.74 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -175.82 122.75 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.855 0.359 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -174.53 163.05 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.27 159.36 9.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.3 t -67.85 -25.74 65.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 58.42 36.33 25.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.27 104.67 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -165.99 178.16 6.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.695 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -92.21 112.76 24.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.14 141.28 40.85 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.569 0.7 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.4 Cg_endo -69.71 -164.97 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -121.93 5.51 9.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -119.83 -31.08 4.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.15 81.53 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -64.4 128.28 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 62.44 160.47 0.12 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.37 35.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.5 p -61.46 143.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.79 131.48 39.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.543 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.75 -166.04 0.17 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.737 2.291 . . . . 0.0 112.315 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.4 m -107.34 -67.57 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -52.53 -60.51 3.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.692 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.54 -27.34 25.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 130' ' ' PRO . 1.8 tt -64.33 -29.77 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -10.04 18.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.84 -3.1 4.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.5 p -93.82 147.61 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.22 76.1 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.87 0.75 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -162.45 169.42 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.928 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.45 ' CG1' ' HB1' ' A' ' 172' ' ' ALA . 43.7 t -129.03 112.85 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -123.75 104.2 8.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.9 mp -120.32 135.26 55.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -109.05 108.26 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.744 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.4 p90 -133.15 162.6 31.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.1 p -109.69 130.6 55.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.3 mt -96.16 102.76 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -56.71 149.32 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.492 HG23 ' HB3' ' A' ' 192' ' ' GLU . 1.0 OUTLIER -51.37 -25.71 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.0 p -89.09 23.55 2.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.77 48.12 87.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 155' ' ' VAL . 8.3 tttt -121.91 118.13 28.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.3 107.65 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.536 HG23 ' OG1' ' A' ' 147' ' ' THR . 27.2 m -125.63 -177.0 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.89 39.5 30.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -64.26 117.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.33 114.66 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 143' ' ' THR . 2.7 p -84.01 129.7 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.38 -29.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.56 140.28 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.472 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.56 115.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.12 166.33 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.654 0.74 . . . . 0.0 110.857 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.74 -8.28 23.19 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 0.0 112.332 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.76 -168.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -60.31 93.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 60.7 mmm -135.81 -74.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.692 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -111.45 12.73 21.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.65 -42.17 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -63.63 -58.94 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.7 mp0 -54.34 -31.65 54.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 142' ' ' VAL . . . -73.79 -51.76 15.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.4 ttt -60.88 -49.72 76.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -62.54 -31.84 72.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -61.81 -54.04 47.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.525 ' HB3' HD11 ' A' ' 157' ' ' ILE . 3.4 mm? -51.66 -34.03 36.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -77.65 -38.86 46.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -89.08 12.51 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 12.9 m0 -92.48 169.42 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 118.92 10.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 137.35 51.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.68 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.0 tt0 -96.62 137.76 21.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.602 0.715 . . . . 0.0 110.937 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 76.82 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -145.05 115.41 7.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 57.8 mt -78.39 111.26 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.123 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.29 157.0 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -50.1 107.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 129.85 -46.13 1.1 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 157.17 45.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.342 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.624 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.67 -169.97 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.624 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -122.72 -175.85 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.102 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 191' ' ' ILE . 9.8 pt-20 40.27 44.1 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -117.21 105.62 48.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.625 0.726 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 147' ' ' THR . 54.2 Cg_endo -69.74 -8.68 24.22 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.674 2.249 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.36 61.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.695 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 8.8 tp60 -109.57 106.01 15.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.857 0.36 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 58.0 p -111.63 144.1 41.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 198' ' ' VAL . 3.9 p -121.18 117.22 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.2 m -122.86 116.81 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.5 150.21 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -95.33 157.44 15.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -114.05 126.93 55.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -114.8 110.39 19.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 48.3 mm -51.96 142.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.95 136.67 28.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -137.27 71.13 54.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.578 0.704 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 140.52 42.88 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -52.7 165.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.4 t -149.24 142.83 25.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 m -80.47 -31.7 37.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . 63.7 160.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.7 Cg_endo -69.79 101.3 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.3 t -63.99 -30.88 71.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -61.83 -47.17 86.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.36 66.1 1.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -115.11 120.0 38.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -97.15 158.12 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.49 110.81 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -81.89 -25.87 34.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.93 -48.7 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 55.66 56.5 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -79.25 153.13 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.708 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.3 ptm -126.13 130.79 23.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 54.1 Cg_endo -69.72 -164.62 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.729 2.286 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.6 OUTLIER -123.15 5.14 9.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -118.99 -30.11 5.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.7 OUTLIER -131.84 83.47 2.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.38 128.29 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 63.18 158.2 0.12 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.0 Cg_endo -69.79 134.61 28.32 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.332 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -57.6 136.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -86.15 138.31 34.69 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.658 0.742 . . . . 0.0 110.887 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -165.56 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 m -117.36 -30.08 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -87.62 -64.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.65 -27.39 27.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.8 tt -66.4 -57.47 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -71.81 -28.37 63.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -69.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.38 4.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.81 132.9 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.2 mp0 -119.39 109.23 15.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -116.47 -138.31 6.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -158.71 134.56 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 163' ' ' ASN . 10.2 m -106.27 130.56 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 98.2 m -134.97 106.42 6.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.4 mp -113.38 139.0 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.598 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.3 m -114.75 110.85 20.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.802 ' HB3' HD13 ' A' ' 157' ' ' ILE . 13.7 p90 -136.27 166.35 23.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 194' ' ' PRO . 52.4 p -112.43 128.81 56.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.6 mt -94.24 102.52 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.32 146.04 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 192' ' ' GLU . 98.7 m -52.3 -23.89 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.8 p -88.12 22.95 2.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.19 47.97 88.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 118.13 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.33 114.92 22.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.65 174.15 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 t70 61.32 43.7 10.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 146' ' ' PHE . 13.7 mm -65.41 108.72 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -136.66 114.86 11.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.512 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.9 130.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.08 -30.87 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.69 122.97 1.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -141.41 107.91 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.473 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.26 165.29 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.65 0.738 . . . . 0.0 110.898 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.33 23.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.635 2.224 . . . . 0.0 112.357 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -162.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -63.43 85.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 68.3 mmm -128.34 -68.1 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.546 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -121.6 -4.71 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 9.0 tt0 -56.48 -54.4 46.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -55.27 -34.1 63.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.653 ' HB3' HG13 ' A' ' 128' ' ' VAL . 17.6 mm-40 -75.19 -41.89 56.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.32 80.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.557 ' HA ' HD21 ' A' ' 144' ' ' LEU . 45.2 ttp -64.68 -54.5 30.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -58.51 -32.85 69.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.5 -54.57 7.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -50.86 -36.02 35.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -78.51 -35.45 46.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -88.09 9.32 23.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.62 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -86.56 162.31 18.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 126.95 32.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.13 130.5 54.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.756 ' HB2' HD21 ' A' ' 122' ' ' LEU . 11.2 tt0 -88.04 136.23 32.45 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.586 0.708 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -9.12 25.33 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -57.2 110.77 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.73 115.58 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.27 153.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.6 108.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.9 -41.54 1.6 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.43 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -139.32 125.47 20.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.609 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -121.59 -171.96 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.069 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.609 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -118.87 -176.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.1 mt-10 66.26 76.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 15.6 pt20 -151.08 93.06 3.7 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.631 0.729 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.741 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.26 20.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.64 2.227 . . . . 0.0 112.333 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.96 49.92 0.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.708 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.8 tp-100 -90.31 122.51 33.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.598 HG22 ' OG ' ' A' ' 145' ' ' SER . 23.8 p -125.13 140.1 53.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 176' ' ' LEU . 2.7 p -120.64 110.87 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 53.9 m -120.82 115.79 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.431 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.8 p -138.96 142.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.27 144.29 26.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.46 106.93 17.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 127.62 53.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 134' ' ' LEU . 38.9 mm -78.75 143.42 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -101.88 -176.7 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.2 mttp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.869 0.366 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.21 68.03 0.65 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.57 69.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.256 . . . . 0.0 112.345 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.8 103.06 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -132.05 90.29 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -96.4 126.23 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -178.03 160.45 1.25 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.698 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.8 Cg_endo -69.77 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.31 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.6 m -157.55 136.14 11.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -93.15 -63.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.3 133.1 7.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -125.37 -179.26 4.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -86.87 -72.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.47 41.6 4.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 t -79.56 -26.52 41.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.907 0.384 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -52.07 153.06 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -121.51 79.39 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -147.66 -176.89 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.705 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -54.99 104.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.066 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.6 mtt -141.19 129.32 12.23 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.583 0.706 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -164.77 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.665 2.243 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -124.82 6.21 8.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -121.14 -30.08 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.453 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.5 OUTLIER -131.36 81.85 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.833 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.3 m -64.62 128.19 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 62.46 160.16 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.7 0.762 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.77 137.33 35.17 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.246 . . . . 0.0 112.361 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.4 p -62.03 145.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.14 136.77 20.87 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.72 0.772 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.78 -166.55 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.5 t -119.41 -33.01 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -87.36 -57.64 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.671 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.73 -27.78 30.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 204' ' ' ILE . 15.9 tp -63.27 -54.69 33.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.947 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -74.62 -10.23 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -69.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.37 4.31 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.516 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.54 147.2 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -120.42 81.11 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.01 -136.97 1.61 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.468 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.12 169.85 23.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.895 0.378 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.37 112.48 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.47 106.82 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.766 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.5 mp -118.63 134.48 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.27 105.62 15.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.791 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.7 p90 -132.22 166.67 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 194' ' ' PRO . 81.3 p -118.98 126.03 50.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.8 mt -85.19 107.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -65.32 146.89 54.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 192' ' ' GLU . 2.4 m -51.87 -24.11 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.104 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.9 p -86.92 23.28 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.32 46.83 92.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -134.4 118.34 17.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -79.6 116.68 19.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.138 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.28 175.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.7 t0 61.98 36.54 15.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.791 HD13 ' HB3' ' A' ' 146' ' ' PHE . 19.0 mm -58.66 98.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -125.45 113.85 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.766 HG22 ' HG ' ' A' ' 144' ' ' LEU . 39.2 t -77.14 128.7 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.42 -36.52 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.78 141.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.37 129.28 4.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 54.14 165.56 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.612 0.72 . . . . 0.0 110.879 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.4 Cg_endo -69.76 -10.47 28.64 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -179.92 -169.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 96.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 79.5 mmm -140.61 -75.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.671 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -109.76 7.9 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.36 -33.94 76.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -71.23 -58.43 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.8 mp0 -54.86 -33.26 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.62 44.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.625 ' HA ' HD21 ' A' ' 144' ' ' LEU . 3.7 ttt -65.3 -54.26 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.15 -32.51 62.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.58 -58.55 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.637 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.12 -35.95 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -32.54 49.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.99 12.29 24.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.453 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 14.8 m0 -88.57 162.18 16.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 129.97 38.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 146.21 44.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.79 ' HB2' HD21 ' A' ' 122' ' ' LEU . 14.0 tp60 -106.63 137.26 19.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.698 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.483 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo -69.72 75.68 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.399 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.479 ' C ' HD11 ' A' ' 191' ' ' ILE . 66.1 mt-30 -147.48 112.06 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.664 HG12 HD12 ' A' ' 191' ' ' ILE . 25.0 mt -78.65 117.9 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.73 153.82 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.132 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.88 107.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.21 -47.0 1.04 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -140.57 152.14 45.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.26 -172.18 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER -126.34 -173.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.714 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.9 pt-20 44.62 36.69 1.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 6.6 tt0 -106.91 104.65 52.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.621 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.76 -7.76 21.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.33 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -123.18 71.02 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.705 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.0 tp60 -119.13 125.02 48.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.7 p -128.25 143.97 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.7 p -120.58 110.98 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.6 m -119.17 114.17 22.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.557 HG11 ' HG3' ' A' ' 127' ' ' PRO . 11.2 p -139.13 150.77 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -96.25 139.21 32.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.0 115.94 28.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -109.64 131.23 55.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 134' ' ' LEU . 48.8 mm -72.54 142.96 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.43 119.1 4.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 64.48 153.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.604 0.716 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 139.19 39.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.355 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -102.94 93.77 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.7 p -76.46 112.06 12.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.195 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.5 m -134.85 121.5 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -80.29 160.39 68.01 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 111.078 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.4 Cg_endo -69.79 177.49 5.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -147.81 162.72 38.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.169 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -172.6 138.0 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.97 122.89 2.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -175.69 112.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.86 150.83 43.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.12 119.79 2.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -85.52 -45.81 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.887 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -99.41 50.58 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -88.93 115.2 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -115.88 -76.51 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.633 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -62.97 103.38 0.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 15.8 ptp -142.18 132.49 12.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -165.66 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.713 2.275 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.1 -2.38 15.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.974 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -117.62 -18.7 9.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -131.61 85.03 2.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 t -64.77 -14.6 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 11.3 pt-20 -147.43 156.12 45.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.75 142.1 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.349 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.6 p -63.61 141.42 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.35 143.2 26.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.962 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.6 Cg_endo -69.78 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.349 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.3 m -119.32 -30.4 4.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -87.62 -57.65 2.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.77 -27.76 30.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 204' ' ' ILE . 5.4 tp -69.73 -56.6 6.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -66.63 -34.66 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -52.38 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.41 3.05 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.504 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.0 t -74.27 131.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.814 0.34 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.45 95.32 4.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.42 -132.46 6.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.538 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.53 170.27 20.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 t -140.22 115.73 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -128.61 107.61 9.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 173' ' ' MET . 5.6 mp -115.56 135.97 53.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -106.4 104.5 14.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.689 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.4 p90 -129.62 165.9 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.8 p -121.57 138.72 54.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.406 HD12 ' NE2' ' A' ' 193' ' ' GLN . 75.0 mt -100.45 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.1 147.75 33.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.4 m -51.29 -23.01 3.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.4 p -83.18 22.41 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 55.67 45.32 85.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.548 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.97 132.97 33.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.762 0.315 . . . . 0.0 110.932 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.18 136.39 33.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.79 168.44 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 t70 64.15 44.11 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.829 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -62.25 118.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -142.47 115.58 8.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 144' ' ' LEU . 99.2 t -76.38 132.7 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 145' ' ' SER . 48.6 t -96.9 -34.09 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.19 122.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.645 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -151.34 141.21 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.45 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 55.67 163.66 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 0.0 110.907 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -10.17 27.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.44 -39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 178.23 99.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 70.2 mmm -145.32 -60.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.428 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -112.67 13.12 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.645 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.6 tt0 -66.72 -53.08 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -37.93 73.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HB3' HG13 ' A' ' 128' ' ' VAL . 23.8 mm-40 -75.04 -34.12 61.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.89 -43.0 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.566 ' HA ' HD21 ' A' ' 144' ' ' LEU . 35.4 ttp -69.79 -54.32 14.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -57.09 -31.61 65.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.25 -54.09 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -49.9 -32.53 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -78.45 -62.82 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.932 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -52.51 -28.52 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -51.59 165.64 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -142.39 117.93 10.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 143.07 42.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -102.93 136.91 19.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.29 32.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -53.12 111.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.81 113.31 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.33 153.68 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -51.42 108.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.68 -44.88 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -141.72 127.63 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.566 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -119.0 -171.99 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -116.79 -176.08 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.43 66.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.9 pt20 -140.91 96.64 7.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.661 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.72 -8.11 22.77 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.677 2.251 . . . . 0.0 112.381 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -118.4 58.81 0.51 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.633 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 5.5 tp60 -100.75 99.48 10.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 10.7 p -108.89 138.44 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' VAL . 5.0 p -120.35 118.64 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 1.1 m -121.55 115.74 23.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 127' ' ' PRO . 5.1 p -137.32 127.29 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 131.83 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -96.09 115.12 26.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 141.12 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 134' ' ' LEU . 32.7 mm -91.34 139.58 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.49 134.46 54.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 57.52 71.62 1.06 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.613 0.721 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 177.92 5.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -100.22 152.6 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 p -114.93 174.48 5.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.8 p -165.0 123.15 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -179.27 -61.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.603 0.716 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 53.5 Cg_endo -69.71 137.52 35.79 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.691 2.26 . . . . 0.0 112.383 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 m -89.3 -67.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.13 -175.14 3.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.91 170.36 31.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -149.52 135.31 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -147.74 127.06 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.61 -38.0 1.68 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 t -66.1 -42.17 89.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -115.14 144.23 43.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.7 34.65 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.55 ' NE2' ' H ' ' A' ' 199' ' ' THR . 32.4 mt-30 -93.24 -178.71 4.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -62.05 103.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 58.6 mtt -141.5 137.93 16.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -165.31 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -114.6 -0.68 13.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -117.0 -18.6 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.61 81.9 2.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.25 -32.12 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -133.6 158.5 75.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.609 0.718 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.592 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.74 143.93 52.51 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.6 p -60.55 144.41 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.68 138.93 19.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.9 Cg_endo -69.73 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 0.0 112.402 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.6 t -118.4 -30.3 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -87.45 -56.91 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.694 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.42 -28.01 27.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 204' ' ' ILE . 2.2 tp -67.23 -40.42 86.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.915 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -84.22 -16.85 41.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.43 -69.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.94 3.44 5.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.18 147.44 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -115.62 66.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.49 178.79 22.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.45 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -124.82 137.64 54.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.361 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.712 HG11 ' CB ' ' A' ' 172' ' ' ALA . 14.9 t -106.48 140.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.0 m -144.08 105.68 4.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 159' ' ' VAL . 7.8 mp -115.15 138.63 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 p -114.51 119.25 36.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' A' ' 157' ' ' ILE . 14.9 p90 -140.17 166.85 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 194' ' ' PRO . 64.4 p -110.08 136.19 49.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 193' ' ' GLN . 16.5 mt -100.81 102.98 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.4 146.44 44.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.7 m -52.49 -23.35 6.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.2 p -88.6 22.98 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.65 47.31 91.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 155' ' ' VAL . 24.0 ttmt -119.54 145.73 46.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -110.27 107.02 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.656 HG13 ' HG2' ' A' ' 153' ' ' LYS . 31.3 m -130.03 -175.17 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.172 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 53.53 43.89 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -67.82 115.02 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -143.69 114.79 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG23 HD12 ' A' ' 144' ' ' LEU . 2.4 p -87.49 125.22 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.35 -32.94 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.01 121.97 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 159' ' ' VAL . . . -132.25 98.79 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 168' ' ' PHE . 0.0 OUTLIER 54.74 169.99 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.639 0.733 . . . . 0.0 110.869 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.5 Cg_endo -69.78 -7.06 20.1 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.652 2.234 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -178.79 -170.98 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.34 93.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.5 mmm -134.57 -71.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.694 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -117.56 18.34 14.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -68.33 -48.46 64.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -62.53 -45.6 92.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.615 ' HB3' HG13 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -60.7 -42.93 98.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.712 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.29 -45.24 66.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.524 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.0 ttt -62.69 -51.66 66.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.64 -30.84 71.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -62.79 -50.5 70.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 146' ' ' PHE . 1.8 mm? -51.48 -29.05 15.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -77.65 -62.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -56.33 -24.03 41.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -54.14 167.98 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.61 119.6 11.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.57 136.01 53.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 1.6 tt0 -110.01 140.18 22.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 73.55 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.539 ' H ' HD11 ' A' ' 191' ' ' ILE . 18.8 mt-30 -125.41 114.55 18.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.17 115.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.33 153.38 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.53 108.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.77 -35.86 3.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 119.59 8.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.899 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.515 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -129.93 -175.93 3.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -115.23 178.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.126 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.6 mt-10 66.62 69.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 148' ' ' ILE . 13.2 pt20 -151.37 97.66 3.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.583 0.706 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.728 ' O ' HG22 ' A' ' 147' ' ' THR . 53.9 Cg_endo -69.78 -6.39 18.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -119.6 75.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 5.9 mm-40 -116.33 137.48 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.3 p -135.98 136.39 40.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.2 p -120.32 113.05 38.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.55 ' H ' ' NE2' ' A' ' 118' ' ' GLN . 78.6 m -122.21 120.04 33.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.592 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.3 p -137.55 142.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -85.84 118.05 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -80.18 112.95 17.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.23 136.98 42.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 134' ' ' LEU . 48.3 mm -76.57 141.31 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.136 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 62.49 57.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -126.58 157.27 71.45 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.538 0.685 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 115.77 4.25 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -173.91 130.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.4 p -150.94 117.56 5.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.4 m -61.5 -26.35 67.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.81 73.91 0.46 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.586 0.708 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 79.16 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.757 2.305 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.4 m -120.22 72.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -124.92 156.45 37.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.3 42.07 1.49 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.31 65.86 1.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -77.63 59.85 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.15 98.33 2.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.3 m -71.97 -26.04 62.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.891 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -95.45 111.73 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -113.96 107.4 15.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -106.51 -173.28 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.728 ' HB2' ' OE1' ' A' ' 196' ' ' GLN . . . -87.86 104.18 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.082 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 39.1 mtm -123.87 143.0 40.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.564 0.697 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.4 Cg_endo -69.81 -163.93 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.685 2.256 . . . . 0.0 112.352 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -127.05 4.86 6.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.87 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -120.84 -29.18 4.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 2.4 mpt_? -131.38 81.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.1 m -68.28 132.78 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 63.58 155.85 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 136.12 32.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.697 2.264 . . . . 0.0 112.403 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.6 p -60.37 135.33 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.699 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -83.15 138.9 42.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -165.11 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.34 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 95.9 p -117.11 -30.09 5.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -87.72 -66.41 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.43 -27.48 24.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 129' ' ' TYR . 9.7 tt -65.15 -57.34 8.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -73.39 -26.39 60.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -51.54 -72.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 133.51 1.36 3.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 167' ' ' MET . 2.4 t -82.87 138.78 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.145 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -122.84 99.24 6.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -102.61 -147.54 19.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.41 132.43 19.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 m -107.52 132.87 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 159' ' ' VAL . 38.2 m -138.59 106.69 5.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 173' ' ' MET . 7.5 mp -116.14 137.99 51.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 p -114.27 122.02 45.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.816 ' HB3' HD13 ' A' ' 157' ' ' ILE . 22.0 p90 -145.06 167.17 23.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 194' ' ' PRO . 63.2 p -115.6 138.94 50.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.0 102.69 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -56.27 146.68 23.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' HG2' ' A' ' 192' ' ' GLU . 92.4 m -51.8 -24.49 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.2 p -88.15 23.14 2.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.65 48.64 85.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -127.29 118.53 24.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.754 0.311 . . . . 0.0 110.882 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.06 113.26 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.407 HG13 ' HG2' ' A' ' 153' ' ' LYS . 32.7 m -133.98 -175.13 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.5 t70 58.59 36.03 24.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.881 HD11 HD12 ' A' ' 176' ' ' LEU . 11.5 mm -59.23 111.21 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -138.31 114.86 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.465 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -86.12 128.12 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.02 -28.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.23 123.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -143.75 112.06 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 49.38 165.2 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.78 -34.19 15.02 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.666 2.244 . . . . 0.0 112.309 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.55 -165.51 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.08 89.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 138' ' ' VAL . 16.1 mtp -131.64 -70.36 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -117.02 -18.0 10.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.433 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 21.2 tt0 -50.02 -53.48 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.51 -33.54 63.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 128' ' ' VAL . 19.8 mm-40 -75.33 -46.83 30.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.7 98.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.074 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.616 ' HA ' HD21 ' A' ' 144' ' ' LEU . 22.7 ttt -63.53 -53.0 58.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.92 -32.83 74.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -71.0 -55.18 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.881 HD12 HD11 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.4 -38.43 53.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -78.14 -34.78 49.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -86.88 8.21 23.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.694 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 14.9 m0 -85.25 161.75 19.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -128.63 128.28 43.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.8 124.93 44.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.791 ' HB2' HD21 ' A' ' 122' ' ' LEU . 9.9 tp60 -86.03 134.94 37.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.699 . . . . 0.0 110.944 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -9.8 27.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -51.63 119.48 4.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 99.4 mt -91.35 113.05 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.79 153.12 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.157 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -51.1 107.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.14 -30.69 3.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -146.8 148.27 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.632 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.95 -169.03 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.632 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -117.99 -174.97 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.533 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.7 mt-10 68.5 55.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -129.87 89.87 44.67 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.584 0.706 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.75 -5.2 15.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.12 68.92 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.536 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.728 ' OE1' ' HB2' ' A' ' 119' ' ' ALA . 24.9 mm-40 -109.33 133.67 52.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 20.1 p -136.63 137.23 39.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.27 110.51 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.416 HG23 ' OG1' ' A' ' 143' ' ' THR . 4.1 m -124.62 110.22 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.1 143.61 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.62 148.87 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.8 105.45 15.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.7 124.62 43.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.492 HG21 ' HA2' ' A' ' 137' ' ' GLY . 42.8 mm -80.7 140.4 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.84 178.17 5.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -124.57 157.33 65.8 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 172.97 11.68 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.246 . . . . 0.0 112.322 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.62 92.15 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -112.25 126.26 55.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m 60.91 29.39 18.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -119.1 160.42 41.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 0.0 111.112 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.7 Cg_endo -69.81 171.61 14.19 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.358 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -122.55 96.69 5.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -77.6 168.41 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.89 86.75 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -143.18 -177.79 5.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.77 179.07 5.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.13 141.75 3.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -78.46 -52.88 7.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 54.8 48.52 19.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -125.31 63.29 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -147.51 171.98 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -55.22 104.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.087 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.1 ptm -137.57 122.15 12.23 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -165.54 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.711 2.274 . . . . 0.0 112.363 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.8 OUTLIER -113.73 4.09 15.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -120.89 -29.73 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 1.8 mpt_? -131.72 81.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.99 -33.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.135 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.66 159.42 58.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.666 0.746 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 139.79 41.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 171' ' ' GLU . 12.1 p -58.11 135.52 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -91.47 141.45 25.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.662 0.744 . . . . 0.0 110.912 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -165.67 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -117.47 -35.02 4.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -87.43 -60.33 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.7 -27.52 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.115 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.7 tt -65.77 -32.51 74.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -99.29 -11.17 21.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.26 -8.81 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.18 147.02 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -121.99 85.13 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.36 -139.21 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.11 170.05 22.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.79 122.89 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -131.83 107.28 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.7 mp -120.96 130.66 53.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.64 106.08 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE1' HD11 ' A' ' 176' ' ' LEU . 18.9 p90 -132.82 166.43 22.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.7 p -118.15 130.39 56.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.523 HD12 ' NE2' ' A' ' 193' ' ' GLN . 57.7 mt -98.32 125.01 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.9 p30 -72.2 158.01 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.3 -22.16 2.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.7 p -80.66 22.58 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 52.02 46.42 55.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.434 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.23 131.9 35.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 146' ' ' PHE . . . -76.48 141.13 41.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.1 m -151.1 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 56.71 39.75 29.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.6 mm -51.54 113.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -134.25 114.55 13.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.925 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 144' ' ' LEU . 58.4 t -83.49 139.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -109.38 -25.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.0 122.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -142.94 109.44 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.33 165.98 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.889 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.1 Cg_endo -69.71 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.731 2.287 . . . . 0.0 112.364 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.31 -162.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -69.36 79.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 72.0 mmm -120.84 -65.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.624 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -119.6 -5.54 10.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 19.7 tt0 -55.22 -53.2 59.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -53.29 -47.51 69.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.785 ' HB3' HG13 ' A' ' 128' ' ' VAL . 25.6 mm-40 -66.05 -33.47 75.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.29 -45.11 66.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.439 ' HA ' HD21 ' A' ' 144' ' ' LEU . 7.0 ttt -68.61 -55.63 10.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -54.51 -32.55 58.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -69.57 -47.23 64.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -50.38 -32.76 18.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -61.79 1.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -26.33 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 18.7 m0 -53.06 151.28 4.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -124.73 117.73 24.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.42 143.45 42.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.958 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.479 ' HB2' HD21 ' A' ' 122' ' ' LEU . 47.4 tt0 -111.22 137.46 21.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.6 0.714 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 74.54 1.31 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.332 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.23 112.93 8.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.82 103.8 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 187' ' ' ASP . 8.6 p -121.86 157.0 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 186' ' ' VAL . 24.7 m-20 -50.4 108.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.59 -46.81 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.528 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 161.0 39.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.511 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -138.05 -169.08 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.79 -175.55 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.527 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.1 pt-20 38.75 56.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.523 ' NE2' HD12 ' A' ' 148' ' ' ILE . 14.8 pt20 -112.65 103.32 55.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.8 -7.73 21.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.332 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.03 59.0 0.69 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.672 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 4.5 tp60 -100.57 109.64 21.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.3 p -113.51 141.37 47.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.65 126.09 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 5.2 m -124.65 110.15 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.06 121.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -83.39 132.88 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -97.75 119.95 37.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -124.92 120.45 31.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.3 mm -56.99 140.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -86.1 177.36 7.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.1 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.81 0.338 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -153.06 139.75 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.805 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 80.07 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -55.92 121.57 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.0 t -112.59 143.78 43.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.62 84.2 3.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -139.38 160.46 61.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.9 Cg_endo -69.79 -172.77 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.5 t -86.49 147.9 25.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -174.34 126.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.73 173.13 20.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -100.76 178.99 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -113.55 -29.19 7.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.56 89.53 1.76 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -86.02 -34.54 20.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 0.0 110.843 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.37 172.82 8.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -122.58 26.96 8.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 170.58 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -79.3 103.58 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.9 ptm -127.45 143.69 48.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -164.93 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD21 ' CB ' ' A' ' 182' ' ' GLN . 0.7 OUTLIER -125.44 5.54 7.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.939 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -120.97 -30.13 4.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.449 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.3 OUTLIER -131.44 81.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.73 130.29 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 62.42 160.72 0.12 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 138.67 38.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.73 HG13 ' HB2' ' A' ' 171' ' ' GLU . 6.5 p -64.77 113.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.96 137.15 73.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -165.83 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.654 2.236 . . . . 0.0 112.324 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.8 t -118.82 -35.2 3.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -86.73 -58.71 2.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.78 -27.37 28.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.7 tt -66.08 -30.0 70.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -104.46 -3.59 23.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -70.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.53 -3.48 4.3 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.428 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.2 p -101.35 148.22 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -114.79 75.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.89 167.53 52.81 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -116.61 139.66 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -108.67 134.72 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 m -133.05 107.42 8.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.153 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -114.26 130.51 56.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.2 p -105.66 108.58 20.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.515 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.7 p90 -131.4 165.8 22.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -112.13 126.97 55.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.618 HD11 ' HB1' ' A' ' 119' ' ' ALA . 77.8 mt -96.43 102.72 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.93 148.73 34.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.7 m -51.99 -24.6 6.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.172 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.33 23.44 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.88 47.65 89.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.15 134.25 55.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -106.38 106.83 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 m -132.97 177.22 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t70 63.58 38.43 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 146' ' ' PHE . 18.9 mm -58.03 98.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.01 115.17 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG22 ' HG ' ' A' ' 144' ' ' LEU . 44.9 t -83.34 126.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.2 t -92.56 -32.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.98 123.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.486 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -148.19 110.6 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 163' ' ' ASN . 1.8 p30 58.02 159.39 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -49.43 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -133.99 166.87 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -40.54 103.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.428 ' CE ' HG12 ' A' ' 138' ' ' VAL . 68.5 mmm -142.34 -69.78 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.661 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -121.57 6.14 10.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -66.63 -43.37 84.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -56.87 -60.39 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.73 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.2 pp20? -57.1 -41.68 79.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.26 92.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.633 ' HA ' HD21 ' A' ' 144' ' ' LEU . 2.8 ttt -72.2 -57.33 4.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -56.1 -32.9 64.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.92 -57.26 10.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.547 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -51.15 -34.82 32.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.942 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.37 -35.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.37 10.36 20.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.547 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 17.9 m0 -89.76 158.48 17.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -130.73 129.87 43.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.17 142.89 48.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.585 ' CB ' HD21 ' A' ' 122' ' ' LEU . 1.6 tp-100 -110.86 135.76 20.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 0.0 110.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 191' ' ' ILE . 53.7 Cg_endo -69.78 92.25 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.651 2.234 . . . . 0.0 112.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -145.0 110.44 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.682 HG12 HD12 ' A' ' 191' ' ' ILE . 42.7 mt -85.39 113.62 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 p -130.62 149.82 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -51.69 107.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.35 -34.07 4.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -144.55 129.49 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 185' ' ' ILE . . . -138.12 -169.31 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.091 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER -119.39 -175.52 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.9 mt-10 72.55 79.52 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -152.54 96.33 3.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.627 0.727 . . . . 0.0 110.928 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.73 -6.93 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.03 0.76 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -94.18 144.45 25.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.921 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 19.9 p -142.38 143.36 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.185 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.0 p -120.89 112.9 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.16 112.11 18.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.22 151.35 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.73 159.94 14.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.4 105.83 12.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -91.32 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 43.8 mm -53.02 141.89 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -51.75 158.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.65 157.29 77.58 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.622 0.725 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 166.14 28.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -110.96 121.93 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -123.25 137.13 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.1 t -131.13 -56.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . . . -179.2 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 107' ' ' ALA . 53.4 Cg_endo -69.77 164.98 32.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.2 m 57.68 37.07 27.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -89.93 63.68 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.18 81.98 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -109.58 82.01 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.822 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.73 159.02 21.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.11 57.89 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -79.41 -26.41 41.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -153.22 143.38 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -91.96 100.94 13.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -88.31 148.45 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -84.98 103.58 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.2 ptm -122.16 147.32 49.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.8 Cg_endo -69.76 -164.6 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.67 2.246 . . . . 0.0 112.387 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -126.49 4.78 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -120.31 -28.84 4.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.2 OUTLIER -131.46 81.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.82 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.56 129.87 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 62.34 160.67 0.12 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.5 Cg_endo -69.77 143.66 51.5 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.704 2.269 . . . . 0.0 112.291 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 171' ' ' GLU . 9.9 p -69.69 145.44 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.63 135.71 33.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.722 0.772 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -168.58 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 56.2 m -114.71 -40.77 3.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -77.93 -60.64 2.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.49 -27.18 23.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 134' ' ' LEU . 1.4 tt -65.51 -31.96 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -101.29 -7.62 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.2 tmt_? -58.04 -69.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.13 -0.8 4.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.444 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.07 147.45 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 204' ' ' ILE . 0.6 OUTLIER -123.88 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.88 -149.23 24.59 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -141.13 170.29 16.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 172' ' ' ALA . 47.5 t -136.86 129.86 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.151 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 m -132.77 107.43 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.736 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.0 mp -116.42 132.57 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 197' ' ' THR . 17.9 m -106.37 103.67 13.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.5 p90 -128.07 166.35 18.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 194' ' ' PRO . 30.7 p -117.95 147.06 43.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.67 HD11 ' HB1' ' A' ' 119' ' ' ALA . 52.0 mt -109.54 102.45 14.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.159 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.82 150.83 7.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.3 m -50.08 -31.39 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.157 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 151' ' ' THR . 1.6 t -87.88 24.42 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.46 52.59 52.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -124.33 117.72 25.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.73 118.95 24.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.084 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 175.67 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.8 t70 64.33 43.2 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 146' ' ' PHE . 16.3 mm -61.09 100.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -124.3 114.02 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.736 HG22 ' HG ' ' A' ' 144' ' ' LEU . 98.6 t -82.57 131.84 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.83 -31.28 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.83 124.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 163' ' ' ASN . . . -148.99 114.95 5.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 50.64 166.49 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.8 Cg_endo -69.71 -33.24 17.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.621 2.214 . . . . 0.0 112.421 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -150.25 -164.74 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -66.84 83.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 77.5 mmm -121.59 -69.76 0.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.673 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -115.11 -8.44 12.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.69 -34.88 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -64.24 -43.68 94.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.554 ' HB3' HG13 ' A' ' 128' ' ' VAL . 4.2 mp0 -74.91 -38.13 61.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.734 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -67.9 -48.71 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.649 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.1 ttt -57.95 -56.45 21.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -59.61 -30.87 68.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.12 -53.5 44.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 179' ' ' TRP . 0.0 OUTLIER -52.63 -34.69 52.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -78.87 -35.96 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -87.05 7.39 28.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 16.4 m0 -85.12 161.78 19.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 126.68 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.57 143.44 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.659 ' HB2' HD21 ' A' ' 122' ' ' LEU . 5.3 tt0 -106.84 138.33 19.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -9.12 25.32 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.691 2.26 . . . . 0.0 112.369 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -52.03 119.53 4.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.43 103.78 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.7 155.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -50.63 107.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.65 -56.81 0.71 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.47 157.63 34.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.526 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.84 -168.83 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.098 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -113.95 -174.92 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 191' ' ' ILE . 1.9 mt-10 68.53 85.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -152.89 88.85 3.81 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 0.0 110.932 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.72 -5.4 16.1 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.629 2.219 . . . . 0.0 112.355 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.41 67.67 0.56 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.61 138.31 42.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.927 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 145' ' ' SER . 33.1 p -139.44 137.14 35.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 198' ' ' VAL . 4.0 p -120.61 116.85 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 6.9 m -118.03 120.33 37.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.4 p -137.71 142.66 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.34 110.33 22.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -65.7 157.34 30.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -147.74 105.93 3.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.42 HG12 ' HG3' ' A' ' 139' ' ' GLU . 48.7 mm -50.79 144.11 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.97 -174.72 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.82 0.343 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -132.04 160.6 67.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 109.52 2.34 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.366 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -91.5 -64.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -72.99 140.59 47.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.3 t -166.57 128.64 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -133.7 160.44 68.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.572 0.701 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.6 Cg_endo -69.8 -32.99 17.34 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -139.36 -179.77 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.45 -57.39 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.93 64.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.441 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.07 116.95 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -138.75 152.48 47.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.22 53.23 5.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.448 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -82.39 -49.7 9.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -153.51 -178.2 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -109.5 90.25 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HB2' HG23 ' A' ' 198' ' ' VAL . 12.5 pt20 -79.21 155.58 28.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.529 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -89.25 103.78 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 14.0 mtp -112.54 118.3 45.53 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.618 0.723 . . . . 0.0 110.853 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.25 . . . . 0.0 112.395 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 182' ' ' GLN . 1.5 pp -109.53 -0.53 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -116.53 -27.06 6.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -131.77 84.58 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.53 -19.39 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 4.6 pt-20 -145.2 159.29 49.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.8 Cg_endo -69.72 137.69 36.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.696 2.264 . . . . 0.0 112.328 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.7 p -50.49 143.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.667 ' CE1' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -96.81 132.99 24.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.701 0.762 . . . . 0.0 110.902 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -166.9 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.746 2.297 . . . . 0.0 112.34 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 t -122.95 -34.98 3.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -83.89 -49.02 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -67.25 -43.97 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.667 HD23 ' CE1' ' A' ' 129' ' ' TYR . 2.8 tm? -58.83 -28.69 66.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -98.36 -5.26 33.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.958 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -69.89 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.809 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.08 -9.44 3.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.8 147.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -122.78 90.41 3.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.91 -155.79 29.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.441 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -139.77 170.81 15.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 172' ' ' ALA . 4.9 t -136.76 118.1 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 159' ' ' VAL . 22.4 m -115.44 106.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 HG12 ' A' ' 142' ' ' VAL . 8.2 mp -114.71 138.09 51.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.7 p -114.82 107.22 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 157' ' ' ILE . 8.0 p90 -132.28 163.57 28.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 51.0 p -109.82 124.51 51.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 65.8 mt -87.26 102.84 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.126 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.91 145.87 23.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 192' ' ' GLU . 0.7 OUTLIER -52.83 -23.38 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.12 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -88.37 23.02 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.92 47.82 89.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.662 ' HG2' HG13 ' A' ' 155' ' ' VAL . 13.4 tttp -122.07 148.82 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -109.14 106.74 16.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.662 HG13 ' HG2' ' A' ' 153' ' ' LYS . 35.6 m -129.69 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 55.08 25.92 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 146' ' ' PHE . 1.9 mm -53.09 116.96 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -148.89 114.89 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 144' ' ' LEU . 2.5 p -86.97 127.68 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.62 -31.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.58 122.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.867 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 142' ' ' VAL . . . -144.25 113.32 6.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.486 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 52.69 164.17 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.6 0.714 . . . . 0.0 110.913 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -10.41 28.46 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -167.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -60.04 90.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 71.5 mmm -134.06 -63.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -125.3 5.24 7.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -66.95 -45.33 78.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -64.87 -30.79 71.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.5 mp0 -75.14 -49.44 19.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.786 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -68.37 -44.81 74.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.581 ' HA ' HD21 ' A' ' 144' ' ' LEU . 9.0 tpt -57.43 -51.91 67.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -68.38 -30.84 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.57 83.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.04 -30.3 15.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.19 -62.68 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.2 -25.37 32.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -53.38 147.49 10.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.67 119.43 29.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.23 133.77 55.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.554 ' HB2' HD21 ' A' ' 122' ' ' LEU . 46.5 tt0 -94.1 137.7 22.84 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 76.7 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -142.78 116.16 9.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.82 105.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.27 155.84 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -50.6 107.84 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.78 -46.17 1.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -139.03 152.99 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.496 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -135.81 -176.37 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.83 -175.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.523 ' H ' HG22 ' A' ' 191' ' ' ILE . 7.7 pt-20 40.91 40.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.532 ' NE2' HE21 ' A' ' 196' ' ' GLN . 9.2 tt0 -103.5 102.59 30.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 0.0 110.885 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 53.5 Cg_endo -69.76 -34.66 14.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 0.0 112.376 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -99.03 66.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.532 HE21 ' NE2' ' A' ' 193' ' ' GLN . 3.6 tp-100 -112.06 124.07 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.3 p -124.38 138.1 54.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.172 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 118' ' ' GLN . 3.0 p -120.28 114.19 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 24.7 m -111.88 104.75 13.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.143 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 127' ' ' PRO . 17.4 m -100.2 154.07 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 93.06 4.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.22 155.23 35.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -150.86 164.41 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 134' ' ' LEU . 34.5 mm -116.44 139.17 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.6 138.69 45.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 11.0 pttm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -166.24 68.35 1.09 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 177.17 5.79 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.371 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.06 120.5 35.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -117.17 110.95 18.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 t -144.55 115.22 7.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -167.06 160.44 10.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 111.12 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.75 159.93 51.6 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 m -138.39 122.45 17.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -128.52 -57.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.94 -178.1 24.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -151.68 111.2 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -122.28 96.13 4.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -172.22 60.93 0.15 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 t -85.19 -32.61 22.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -121.88 163.37 19.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -81.57 101.21 9.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.951 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.534 ' HB2' HG23 ' A' ' 198' ' ' VAL . 5.3 pt20 -132.18 155.3 48.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 196' ' ' GLN . . . -85.19 103.92 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.092 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.0 ptp -110.68 134.96 20.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.533 0.682 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 -165.89 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.369 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 123' ' ' TYR . 0.4 OUTLIER -109.16 -4.74 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.433 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 t80 -112.83 -20.64 11.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.83 84.91 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.24 -13.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.0 pt-20 -147.6 156.83 45.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.696 0.76 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.763 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.3 Cg_endo -69.74 147.09 62.22 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.656 2.237 . . . . 0.0 112.37 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 171' ' ' GLU . 7.3 p -67.67 140.96 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.94 137.48 20.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.0 110.927 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.72 -170.23 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 0.0 112.346 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m -118.03 -25.09 6.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -86.67 -58.32 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -53.66 -28.48 33.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.8 tp -70.26 -56.74 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -65.08 -36.64 84.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -67.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.48 24.59 1.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.25 138.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -117.77 100.99 7.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.24 17.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.72 160.85 21.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 202' ' ' PHE . 28.3 t -128.46 112.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 199' ' ' THR . 3.8 m -125.78 107.4 10.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 159' ' ' VAL . 7.2 mp -118.64 135.66 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.6 p -106.18 111.68 24.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.819 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.7 ' HB3' HD13 ' A' ' 157' ' ' ILE . 3.2 p90 -136.8 160.42 38.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 194' ' ' PRO . 43.4 p -114.11 134.7 54.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 193' ' ' GLN . 79.2 mt -96.52 102.71 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -56.03 146.01 23.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 79.7 m -52.14 -24.04 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.1 p -87.67 22.85 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 59.75 47.04 92.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -133.79 118.14 17.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 146' ' ' PHE . . . -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -142.4 -178.66 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.6 t0 54.75 51.3 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 146' ' ' PHE . 2.2 mm -70.72 118.54 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -142.26 114.79 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG22 ' HG ' ' A' ' 144' ' ' LEU . 45.0 t -76.72 123.74 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.3 t -82.83 -39.85 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.66 136.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.99 138.21 7.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.62 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 4.7 p30 55.93 162.86 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.9 Cg_endo -69.78 -49.56 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.685 2.257 . . . . 0.0 112.325 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -156.35 91.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' LYS . 84.2 mtt180 51.33 104.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 75.2 mmm -149.12 -54.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.52 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -133.38 3.13 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.62 -34.24 36.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -57.12 4.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.632 ' HB3' HG13 ' A' ' 128' ' ' VAL . 10.7 mp0 -56.97 -31.5 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.85 66.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.093 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.442 ' HA ' HD21 ' A' ' 144' ' ' LEU . 26.6 ttt -71.75 -53.01 14.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -57.81 -31.1 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -68.79 -52.85 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.499 HD21 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -50.11 -33.07 17.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -78.46 -62.31 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -52.23 -27.34 14.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.2 m0 -52.33 164.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -141.52 120.88 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.12 149.03 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.71 129.36 25.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.574 0.702 . . . . 0.0 110.863 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.77 21.89 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.371 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -59.11 111.35 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.0 mt -78.62 115.56 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.39 154.46 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.135 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -51.07 108.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 132.56 -53.02 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -136.17 128.44 30.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.591 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -116.56 -169.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.591 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.5 OUTLIER -117.32 -175.5 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 191' ' ' ILE . 3.0 mt-10 68.27 83.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 148' ' ' ILE . 7.2 pt20 -152.46 91.28 3.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.626 0.727 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.592 ' O ' HG22 ' A' ' 147' ' ' THR . 53.7 Cg_endo -69.78 -7.11 20.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -126.34 62.38 0.61 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 20.9 tp60 -104.98 126.9 52.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.8 p -125.55 139.12 53.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 118' ' ' GLN . 3.4 p -120.72 114.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.49 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -120.32 121.22 38.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.763 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -138.48 144.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -94.87 128.04 41.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 142' ' ' VAL . 3.0 m-85 -87.39 145.28 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -138.65 137.24 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.37 143.4 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.02 115.62 2.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.103 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.4 pttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -117.6 160.61 37.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.604 0.716 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.74 40.94 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.692 2.261 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -94.39 135.72 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -102.29 158.83 15.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.6 p -153.32 166.64 31.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -165.33 70.44 1.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.516 0.674 . . . . 0.0 111.076 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.45 45.07 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.647 2.231 . . . . 0.0 112.344 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.5 m -63.37 157.54 22.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -103.7 163.22 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.97 126.02 4.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.59 148.85 29.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -155.05 151.32 28.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.78 106.01 0.46 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.5 p -82.69 -54.13 5.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -73.64 165.77 24.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -115.88 34.45 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.416 ' CD ' HG23 ' A' ' 198' ' ' VAL . 10.3 pt20 -90.18 -172.19 3.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.717 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . -87.54 103.32 15.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.9 ptp -121.25 145.01 41.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -165.37 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.4 OUTLIER -116.59 -3.4 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -114.29 -16.77 11.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.31 81.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.4 t -57.81 -26.69 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -138.07 157.24 73.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.674 0.75 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.745 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.6 Cg_endo -69.78 137.93 36.55 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.707 2.271 . . . . 0.0 112.343 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.9 p -51.78 133.86 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.7 137.82 33.71 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.67 0.748 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.68 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.78 -165.07 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -128.86 -39.03 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -92.98 -25.23 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.732 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -74.85 -55.09 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 204' ' ' ILE . 0.7 OUTLIER -57.06 -27.67 61.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -90.11 -21.07 22.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -54.6 -65.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.5 2.73 3.96 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.52 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' CG1' ' HE2' ' A' ' 167' ' ' MET . 3.5 p -107.8 147.17 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -120.38 87.23 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.08 22.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -148.39 137.49 21.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 14.6 m -109.88 137.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 199' ' ' THR . 2.1 m -140.16 106.25 5.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -112.26 138.68 48.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.939 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.01 116.59 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.556 ' HB3' HD13 ' A' ' 157' ' ' ILE . 15.0 p90 -135.25 166.51 22.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 194' ' ' PRO . 59.5 p -113.21 128.75 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.743 HD12 HE21 ' A' ' 193' ' ' GLN . 30.5 mt -90.82 106.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.09 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.79 146.94 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 192' ' ' GLU . 3.8 m -52.28 -23.92 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.4 p -87.85 23.15 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.13 46.62 93.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.628 ' HG2' HG13 ' A' ' 155' ' ' VAL . 28.9 ttpt -119.98 148.12 43.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.909 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.04 106.74 15.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.628 HG13 ' HG2' ' A' ' 153' ' ' LYS . 34.0 m -131.12 -178.31 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.9 t0 63.48 26.94 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.626 HD11 HD12 ' A' ' 176' ' ' LEU . 15.3 mm -51.07 102.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -137.24 115.04 11.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 144' ' ' LEU . 2.6 p -84.23 130.39 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.38 -32.85 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.174 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.23 122.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 163' ' ' ASN . . . -156.14 118.95 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.712 HD21 ' N ' ' A' ' 166' ' ' ARG . 0.1 OUTLIER 59.65 157.84 0.1 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.627 0.727 . . . . 0.0 110.881 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 165' ' ' LYS . 53.8 Cg_endo -69.71 -83.71 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 52.8 mttt -123.94 91.59 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.712 ' N ' HD21 ' A' ' 163' ' ' ASN . 9.6 ttm180 53.33 100.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 163' ' ' ASN . 72.5 mmm -152.57 -50.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.732 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -143.07 14.46 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -68.57 -33.67 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -71.64 -56.91 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.689 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.3 pp20? -54.47 -38.04 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.866 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -39.8 76.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.591 ' HA ' HD21 ' A' ' 144' ' ' LEU . 18.3 ttt -72.64 -58.86 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -52.48 -37.26 56.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -63.71 -58.51 6.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -51.53 -33.16 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -78.94 -38.62 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -85.95 7.92 22.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 13.6 m0 -83.93 161.5 20.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.912 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 119.82 20.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.2 145.6 39.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.592 ' HB2' HD21 ' A' ' 122' ' ' LEU . 43.8 tt0 -110.44 138.38 20.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.638 0.733 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 71.58 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -133.99 113.59 12.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.63 116.95 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.45 153.45 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.093 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.55 107.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.8 -33.38 4.45 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -145.13 133.71 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.61 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -127.54 -169.59 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.61 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -122.93 -173.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.8 pt-20 42.15 39.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.743 HE21 HD12 ' A' ' 148' ' ' ILE . 8.1 pt20 -120.87 100.76 45.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 110.928 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 147' ' ' THR . 54.4 Cg_endo -69.72 -6.91 19.7 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.252 . . . . 0.0 112.371 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -109.38 81.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.717 HE21 ' HB2' ' A' ' 119' ' ' ALA . 29.1 mm100 -135.1 125.74 27.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.893 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.6 p -127.69 141.52 51.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HD21 ' A' ' 176' ' ' LEU . 2.6 p -120.63 110.5 28.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -118.45 115.71 25.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.178 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.745 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.1 p -139.35 146.62 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.73 157.37 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.68 110.67 17.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 29.8 ttpp -92.05 143.77 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 134' ' ' LEU . 49.3 mm -85.66 142.52 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -53.84 107.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -127.21 162.54 47.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.58 0.705 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -177.38 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -151.83 -45.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m -147.09 148.52 31.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.9 m -128.69 175.63 8.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.76 73.25 0.42 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.697 . . . . 0.0 111.041 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.65 2.45 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.659 2.239 . . . . 0.0 112.326 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.2 t -164.01 162.65 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -147.62 175.28 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.17 161.53 34.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -145.85 158.78 43.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -174.12 138.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 24.23 21.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 33.0 t -65.12 -28.34 69.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.35 -171.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -80.69 -2.54 47.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 63.81 38.02 9.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' HE21 ' A' ' 196' ' ' GLN . . . -111.34 103.52 11.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.058 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.0 ptm -139.34 150.16 63.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -165.92 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -120.92 0.26 10.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -118.12 -19.11 9.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.86 81.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.03 -31.09 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.1 pt-20 -135.87 160.24 68.14 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.664 0.745 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.7 Cg_endo -69.8 145.71 57.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 171' ' ' GLU . 9.9 p -70.04 136.36 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 142.43 36.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 110.913 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -166.56 0.19 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.657 2.238 . . . . 0.0 112.341 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -119.86 -37.67 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -86.64 -55.77 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -57.84 -26.55 62.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 134' ' ' LEU . 5.0 tt -65.48 -40.36 93.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -11.93 38.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 133' ' ' ALA . 4.0 tmt_? -50.86 -67.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.832 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 122.71 24.7 2.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.42 147.26 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -118.86 109.15 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.6 -133.02 6.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.98 171.07 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.3 t -140.96 115.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 144' ' ' LEU . 1.3 m -128.35 106.35 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.805 ' HG ' HG22 ' A' ' 159' ' ' VAL . 6.5 mp -121.41 140.75 51.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.685 ' HB3' HD13 ' A' ' 157' ' ' ILE . 20.8 p90 -135.41 166.0 24.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 194' ' ' PRO . 80.5 p -113.55 125.36 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 119' ' ' ALA . 30.2 mt -92.93 102.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.44 156.93 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 191' ' ' ILE . 27.6 m -48.67 -34.99 12.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.8 t -87.84 25.14 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.39 51.95 55.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -118.43 118.28 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.04 106.82 18.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.39 172.35 15.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.095 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.2 t0 61.68 45.76 7.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 146' ' ' PHE . 6.0 mm -59.36 108.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -123.06 114.59 20.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.805 HG22 ' HG ' ' A' ' 144' ' ' LEU . 47.5 t -81.94 134.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.14 -32.56 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.13 121.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.449 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -145.48 124.37 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 57.99 162.58 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.915 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.42 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.712 2.275 . . . . 0.0 112.367 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.07 90.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 37.81 88.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 163' ' ' ASN . 85.0 mmm -132.59 -42.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -138.04 14.6 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -66.04 -40.58 91.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -54.63 -64.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HB2' HG13 ' A' ' 128' ' ' VAL . 1.4 pp20? -54.84 -41.53 70.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.51 95.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 16.9 ttt -71.9 -56.5 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -56.6 -32.17 64.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.73 47.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 157' ' ' ILE . 1.2 mm? -51.31 -40.91 60.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.53 -36.54 60.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -81.13 1.22 32.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -86.0 164.32 17.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.54 130.39 32.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.05 127.72 48.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.927 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 122' ' ' LEU . 10.1 tp60 -96.99 128.08 36.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.94 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.232 . . . . 0.0 112.37 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.447 ' C ' HD11 ' A' ' 191' ' ' ILE . 10.0 mt-30 -130.94 117.49 19.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 81.0 mt -85.78 114.42 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.77 152.32 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.5 107.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.63 -30.92 5.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -147.61 131.42 17.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.491 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -128.22 -168.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER -113.77 -176.81 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.2 mt-10 67.3 71.84 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.67 92.71 4.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.624 0.726 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.797 ' O ' HG22 ' A' ' 147' ' ' THR . 52.9 Cg_endo -69.77 -6.49 18.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.331 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.4 83.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.692 HE21 ' HB2' ' A' ' 119' ' ' ALA . 30.7 mm100 -133.65 148.93 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.4 p -149.15 146.09 27.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.52 115.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 114.7 23.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' A' ' 127' ' ' PRO . 12.2 p -137.85 146.61 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -92.12 152.44 19.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -119.42 106.77 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -109.27 125.12 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 38.5 mm -62.95 142.94 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.64 114.12 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.357 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -117.5 68.97 5.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.732 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 127.69 14.96 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.653 2.236 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -65.59 139.78 58.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -110.73 133.31 53.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.3 t -128.77 95.86 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -64.15 160.38 49.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.594 0.711 . . . . 0.0 111.142 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 54.0 Cg_endo -69.67 166.83 26.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 0.0 112.361 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.7 p -70.46 -62.91 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -165.27 159.86 17.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.3 88.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -173.0 110.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -132.44 88.89 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.03 154.9 7.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.486 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.4 m -79.94 -46.92 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 59.59 44.22 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -98.5 67.88 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -140.58 175.47 9.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -54.43 103.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 7.8 ptm -131.2 133.91 25.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.54 0.686 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -165.49 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.404 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.9 OUTLIER -112.55 -3.85 14.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -115.53 -18.29 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.59 81.51 1.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.72 -15.49 16.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 7.8 pt-20 -144.42 155.35 57.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.631 0.729 . . . . 0.0 110.823 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 200' ' ' VAL . 53.9 Cg_endo -69.81 139.73 40.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.622 2.215 . . . . 0.0 112.331 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 171' ' ' GLU . 10.9 p -54.08 133.49 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -75.81 146.94 80.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.704 0.764 . . . . 0.0 110.892 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.499 ' O ' HD23 ' A' ' 134' ' ' LEU . 54.1 Cg_endo -69.77 -165.31 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.38 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.5 t -116.14 -61.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.813 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -87.67 -33.14 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.578 ' HB1' ' HE1' ' A' ' 168' ' ' PHE . . . -64.92 -32.84 74.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HD12 ' A' ' 204' ' ' ILE . 0.5 OUTLIER -70.85 -28.15 64.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -89.47 -39.64 13.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 138' ' ' VAL . 4.6 tmt_? -51.53 -66.65 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' HG21 ' A' ' 204' ' ' ILE . . . 130.74 2.64 4.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.489 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 136' ' ' ARG . 2.1 t -73.12 130.56 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.103 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -117.13 102.44 9.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.79 -136.68 7.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.3 170.84 16.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 202' ' ' PHE . 4.0 t -139.65 112.83 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.2 m -128.76 107.04 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.753 HD12 HG13 ' A' ' 159' ' ' VAL . 6.4 mp -116.65 136.12 53.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.03 108.1 19.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 157' ' ' ILE . 7.2 p90 -132.7 166.15 22.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 194' ' ' PRO . 44.3 p -118.64 128.11 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.1 114.71 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.03 148.92 48.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 192' ' ' GLU . 0.2 OUTLIER -51.57 -24.99 6.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.182 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.5 p -88.1 23.39 2.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 58.99 47.21 91.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.556 ' HG2' HG13 ' A' ' 155' ' ' VAL . 18.4 ttmm -122.88 118.8 28.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.805 0.336 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.56 108.45 18.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.556 HG13 ' HG2' ' A' ' 153' ' ' LYS . 13.2 m -128.7 -177.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.49 41.14 16.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.834 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 146' ' ' PHE . 21.3 mm -63.86 97.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -126.52 114.11 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.753 HG13 HD12 ' A' ' 144' ' ' LEU . 19.3 t -76.95 134.9 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.29 -33.19 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -179.89 136.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.469 ' C ' ' CG ' ' A' ' 163' ' ' ASN . . . -161.24 128.59 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.469 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER 51.15 168.25 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 0.0 110.863 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 54.0 Cg_endo -69.7 -36.33 11.16 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -151.86 -168.81 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.75 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 83.4 mmm -136.62 -65.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.578 ' HE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -118.15 -2.58 11.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.63 -39.78 58.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -71.93 -46.48 57.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' A' ' 128' ' ' VAL . 6.2 mp0 -58.49 -46.75 86.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.74 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.609 ' HA ' HD21 ' A' ' 144' ' ' LEU . 24.7 ttp -60.57 -50.42 73.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -67.55 -32.2 72.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -66.41 -54.96 18.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.513 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -51.65 -36.9 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -79.11 -35.05 42.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -86.6 7.24 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 16.9 m0 -86.77 164.6 16.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -133.97 123.04 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.21 132.06 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HB2' HD21 ' A' ' 122' ' ' LEU . 45.6 tt0 -95.52 137.07 22.05 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.577 0.704 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 76.32 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.445 ' C ' HD11 ' A' ' 191' ' ' ILE . 84.1 mt-30 -134.2 112.44 11.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.8 mt -78.84 115.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.66 152.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -51.07 107.28 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.86 5.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.64 126.92 21.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.554 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -125.15 -167.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.554 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -118.86 -174.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 191' ' ' ILE . 8.5 pt-20 38.99 80.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -148.13 105.07 3.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.586 0.708 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.449 ' O ' HG22 ' A' ' 147' ' ' THR . 53.4 Cg_endo -69.71 -9.55 26.4 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.338 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.97 56.46 0.5 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.55 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 3.2 tp60 -107.97 110.72 22.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 13.6 p -116.61 146.64 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.498 HG11 ' CD2' ' A' ' 176' ' ' LEU . 4.9 p -120.71 117.65 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 9.0 m -117.91 118.12 31.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 127' ' ' PRO . 10.1 p -139.21 149.01 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.8 143.32 31.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.433 ' CE1' HG21 ' A' ' 142' ' ' VAL . 6.5 m-85 -106.03 105.82 16.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -106.39 112.45 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 134' ' ' LEU . 30.0 mm -67.15 137.17 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.35 161.37 11.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.871 0.367 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.99 159.22 31.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -178.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 0.0 112.337 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -154.05 96.9 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 m -134.33 123.47 24.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -155.44 177.45 11.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 108' ' ' PRO . . . -137.28 160.48 65.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.575 0.703 . . . . 0.0 111.095 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 53.9 Cg_endo -69.76 170.06 17.45 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.701 2.267 . . . . 0.0 112.311 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.9 p -110.79 161.58 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -125.2 -73.88 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.14 150.93 23.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -151.78 144.85 24.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -126.25 156.7 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.76 99.44 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 t -77.15 -55.73 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.825 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -153.34 118.81 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.54 25.11 2.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -153.0 174.47 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.587 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -65.97 103.73 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 mtt -131.32 147.43 66.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.534 0.683 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.5 Cg_endo -69.75 -164.83 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -121.38 7.76 10.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -124.55 -33.33 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -130.98 80.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.791 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.03 139.08 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.22 160.29 0.11 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.709 0.766 . . . . 0.0 110.83 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' HG21 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.76 142.6 48.37 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.853 HG13 ' HB3' ' A' ' 171' ' ' GLU . 4.3 p -67.91 114.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 134.21 95.92 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.636 0.731 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.652 ' CG ' ' HB3' ' A' ' 133' ' ' ALA . 54.0 Cg_endo -69.8 -165.25 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.605 2.203 . . . . 0.0 112.379 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.31 -34.59 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.886 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -87.65 -53.08 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.699 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.27 -31.45 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 204' ' ' ILE . 1.8 tp -64.77 -33.53 76.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -93.67 -16.27 24.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.872 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -76.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.24 -11.9 3.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.402 HG12 ' CE ' ' A' ' 167' ' ' MET . 1.3 p -81.87 148.4 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 111.109 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -113.66 61.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.85 -173.31 37.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.479 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -140.83 170.5 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.868 0.366 . . . . 0.0 110.864 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.76 HG11 ' CB ' ' A' ' 172' ' ' ALA . 3.5 t -134.71 111.44 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.413 HG23 ' HB ' ' A' ' 199' ' ' THR . 26.0 m -111.95 104.99 13.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 142' ' ' VAL . 10.9 mp -114.11 135.38 54.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.564 ' OG ' HG22 ' A' ' 197' ' ' THR . 1.5 t -111.76 119.67 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 157' ' ' ILE . 2.9 p90 -139.49 166.02 25.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 194' ' ' PRO . 48.0 p -110.1 133.19 53.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.0 102.91 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.95 149.87 35.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.1 m -51.82 -24.37 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.5 p -88.43 23.31 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.14 43.74 98.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.575 ' HG3' HG13 ' A' ' 155' ' ' VAL . 22.0 tptm -112.86 130.4 56.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.66 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 153' ' ' LYS . 21.1 m -130.56 -177.47 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.52 36.42 19.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.2 mm -66.12 119.33 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.95 114.8 3.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 2.4 p -81.13 118.98 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.59 -36.33 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.3 150.26 28.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.57 -163.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -46.17 165.8 0.18 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.634 0.73 . . . . 0.0 110.913 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 54.4 Cg_endo -69.73 -5.78 17.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -180.0 176.79 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.96 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.2 99.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 133' ' ' ALA . 81.5 mmm -139.32 -75.69 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.699 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -113.61 -19.57 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.51 -36.5 34.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.06 87.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.853 ' HB3' HG13 ' A' ' 128' ' ' VAL . 3.0 mm-40 -71.12 -38.35 72.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.76 ' CB ' HG11 ' A' ' 142' ' ' VAL . . . -70.57 -48.09 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.604 ' HA ' HD21 ' A' ' 144' ' ' LEU . 11.2 ttp -52.1 -51.84 55.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -68.45 -30.66 69.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 128' ' ' VAL . . . -59.89 -49.95 75.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 157' ' ' ILE . 0.6 OUTLIER -51.17 -36.66 42.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -77.62 -35.62 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -84.07 4.05 31.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.463 ' CZ3' HD22 ' A' ' 176' ' ' LEU . 25.0 m0 -85.87 165.19 17.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.97 117.33 11.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.52 132.99 54.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.619 ' HB2' HD21 ' A' ' 122' ' ' LEU . 2.9 tt0 -96.51 140.58 22.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.597 0.713 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.2 22.99 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -51.71 106.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.0 mt -78.95 108.55 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 187' ' ' ASP . 9.3 p -126.24 157.64 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.409 ' N ' HG22 ' A' ' 186' ' ' VAL . 1.9 p-10 -50.57 131.57 25.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 111.88 -47.87 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -148.23 143.29 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -128.03 -168.66 1.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 192' ' ' GLU . 0.4 OUTLIER -113.71 -175.73 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.9 mt-10 66.11 67.44 0.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 194' ' ' PRO . 14.1 pt20 -145.33 96.2 4.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.558 0.694 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.736 ' O ' HG22 ' A' ' 147' ' ' THR . 54.1 Cg_endo -69.74 -8.32 23.31 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.688 2.259 . . . . 0.0 112.328 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -116.59 49.92 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.526 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.587 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 20.7 tp60 -92.17 126.98 37.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.564 HG22 ' OG ' ' A' ' 145' ' ' SER . 52.6 p -128.72 124.35 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 198' ' ' VAL . 3.5 p -120.48 116.0 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 143' ' ' THR . 12.6 t -128.23 141.21 51.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.077 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.416 HG21 ' HD3' ' A' ' 127' ' ' PRO . 3.1 t -133.0 136.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -92.73 121.48 34.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -86.58 137.14 32.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -138.08 119.13 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 134' ' ' LEU . 17.7 mm -70.02 140.82 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.25 171.98 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.8 pttm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.886 0.374 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -136.24 160.57 66.48 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -173.03 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.725 2.283 . . . . 0.0 112.334 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -153.49 117.69 4.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -165.04 153.57 12.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.152 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -157.48 135.81 11.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.1 73.82 37.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.61 0.719 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 174.97 8.76 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.66 2.24 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.0 t -152.89 140.41 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -146.49 169.62 18.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.73 137.57 8.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.68 124.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -155.15 167.67 29.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.58 135.88 2.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.5 p -85.32 -32.93 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.96 55.65 1.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -143.3 41.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -144.36 157.83 44.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -68.99 103.78 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.7 ptp -116.33 140.19 26.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 110.84 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -165.35 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.679 2.253 . . . . 0.0 112.379 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.03 -1.67 13.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -118.0 -19.02 9.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -131.81 82.23 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.27 -18.05 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.6 pt-20 -148.31 161.38 34.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.574 ' HG3' HG11 ' A' ' 200' ' ' VAL . 54.0 Cg_endo -69.75 147.64 63.4 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 171' ' ' GLU . 7.1 p -72.98 131.36 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -84.26 138.92 39.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 0.0 110.902 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -166.69 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.748 2.299 . . . . 0.0 112.347 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m -119.67 -28.9 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -87.26 -58.15 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' CE2' ' A' ' 168' ' ' PHE . . . -61.91 -27.31 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 129' ' ' TYR . 6.7 tt -66.12 -57.48 7.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -25.93 59.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -77.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.858 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 136.15 34.94 0.22 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.4 141.05 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -120.29 98.94 6.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -109.77 -133.16 6.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -158.8 170.26 22.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.41 111.85 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.1 m -127.87 105.73 8.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD21 ' HA ' ' A' ' 173' ' ' MET . 8.5 mp -119.76 134.81 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.2 p -106.12 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 157' ' ' ILE . 6.3 p90 -128.88 166.45 19.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 194' ' ' PRO . 40.4 p -116.81 133.64 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 119' ' ' ALA . 50.1 mt -96.69 104.5 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -60.82 148.18 40.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -51.93 -24.18 6.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.7 p -88.58 23.26 2.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.17 44.65 97.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -116.33 144.56 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -112.05 108.52 17.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.062 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -130.73 -178.58 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.54 32.59 20.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 176' ' ' LEU . 20.8 mm -57.78 98.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -129.55 114.55 16.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 3.5 p -81.68 126.3 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.46 -36.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.075 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.89 139.23 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 163' ' ' ASN . . . -162.25 134.94 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 167' ' ' MET . 2.2 p30 56.91 161.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.631 0.729 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 163' ' ' ASN . 53.2 Cg_endo -69.83 -51.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.6 tptp -148.23 94.78 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 37.88 92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.617 ' H ' ' ND2' ' A' ' 163' ' ' ASN . 64.1 mmm -134.99 -45.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -140.9 17.74 2.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.61 -32.03 71.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -57.54 4.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' HB2' HG13 ' A' ' 128' ' ' VAL . 2.1 pp20? -54.68 -40.88 69.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.1 82.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.644 ' HA ' HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -62.77 -51.0 68.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -65.76 -31.56 72.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.68 -56.23 11.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.569 ' HB3' HD12 ' A' ' 157' ' ' ILE . 0.0 OUTLIER -49.93 -31.29 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.929 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -63.07 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -53.11 -27.68 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -51.64 153.69 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -125.97 124.1 39.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.18 139.6 51.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -103.84 137.31 19.2 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.85 24.64 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.61 2.206 . . . . 0.0 112.373 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -51.88 119.49 4.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.4 mt -92.75 122.04 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.5 153.34 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -51.74 108.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 128.59 -27.34 4.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -153.92 149.61 27.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.551 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -137.6 -169.78 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.551 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.4 OUTLIER -115.38 -174.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.534 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.0 mt-10 69.86 79.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.406 ' NE2' HD12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -145.22 89.59 6.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.518 0.675 . . . . 0.0 110.894 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 147' ' ' THR . 53.2 Cg_endo -69.77 -6.08 17.74 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.679 2.253 . . . . 0.0 112.34 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -127.64 56.01 0.74 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.493 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 22.9 tp60 -97.04 146.25 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 43.7 p -148.35 143.04 26.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 176' ' ' LEU . 3.3 p -120.3 115.11 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 113.65 23.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 127' ' ' PRO . 7.2 p -139.2 132.33 38.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -84.77 155.07 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -114.87 122.1 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -116.18 134.66 54.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.7 mm -87.09 143.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.33 107.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 61.34 71.07 0.82 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -179.29 2.81 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -115.98 170.31 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.8 t -150.75 148.57 28.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -145.08 136.72 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.43 73.8 8.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -177.6 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.2 p -130.76 178.89 6.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -142.08 151.59 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.49 -114.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.88 39.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -63.6 -68.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.89 145.02 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.89 -55.59 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -91.59 120.27 32.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -136.12 -76.23 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -131.32 -174.32 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 196' ' ' GLN . . . -55.56 103.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.1 ptm -127.62 143.77 48.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' TRP . 53.6 Cg_endo -69.76 -164.4 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.643 2.229 . . . . 0.0 112.34 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 182' ' ' GLN . 0.5 OUTLIER -124.0 6.2 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -122.48 -31.61 3.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 179' ' ' TRP . 0.1 OUTLIER -131.31 80.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 27.8 m -66.1 140.56 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 125' ' ' VAL . 1.4 pt-20 54.22 157.92 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 110.881 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 126' ' ' GLU . 54.5 Cg_endo -69.74 136.99 34.45 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 171' ' ' GLU . 8.4 p -62.49 145.85 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.37 134.15 26.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.623 0.725 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 53.8 Cg_endo -69.74 -168.29 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 p -119.98 -35.3 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -79.77 -53.6 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 168' ' ' PHE . . . -53.75 -46.17 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 204' ' ' ILE . 3.0 tp -53.26 -36.47 61.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -77.43 -26.8 51.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -69.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.98 14.57 3.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.52 147.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -118.29 83.45 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.84 -131.36 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -163.67 169.35 18.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 172' ' ' ALA . 2.0 m -134.57 111.24 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 199' ' ' THR . 1.5 m -122.57 106.74 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.174 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HG ' HG22 ' A' ' 159' ' ' VAL . 8.1 mp -122.3 133.65 54.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.6 p -106.56 117.38 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' A' ' 157' ' ' ILE . 5.5 p90 -137.44 164.07 29.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 194' ' ' PRO . 71.6 p -112.34 123.32 50.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.7 mt -87.11 102.17 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.77 146.87 29.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 40.0 m -52.29 -23.9 6.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -88.51 23.07 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 60.86 43.95 98.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.56 ' HG3' HG13 ' A' ' 155' ' ' VAL . 17.3 tptm -116.0 148.31 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -111.48 106.99 16.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.088 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 153' ' ' LYS . 32.6 m -133.27 -175.02 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.122 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 55.24 37.07 28.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.727 HD13 ' HB3' ' A' ' 146' ' ' PHE . 4.7 mm -61.82 109.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -132.07 114.35 14.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.771 HG22 ' HG ' ' A' ' 144' ' ' LEU . 38.8 t -78.93 137.35 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.26 -31.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.43 140.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 169' ' ' GLU . . . -161.42 119.04 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.48 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 0.0 OUTLIER 53.2 166.95 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.617 0.722 . . . . 0.0 110.883 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 163' ' ' ASN . 53.7 Cg_endo -69.77 -15.92 37.27 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.0 -172.89 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -50.29 99.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 86.7 mmm -144.41 -75.36 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -110.45 9.97 23.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 162' ' ' ALA . 2.2 tt0 -67.12 -43.74 81.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -45.59 93.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.454 ' HB3' HG13 ' A' ' 128' ' ' VAL . 5.3 mm-40 -63.76 -50.3 69.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.66 ' HB2' HG11 ' A' ' 142' ' ' VAL . . . -62.13 -38.13 87.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.522 ' HA ' HD21 ' A' ' 144' ' ' LEU . 4.7 ttt -69.55 -55.89 8.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -60.15 -32.12 70.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.57 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' A' ' 157' ' ' ILE . 2.9 mm? -51.55 -36.29 44.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -78.33 -35.11 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -88.26 9.11 24.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 124' ' ' ARG . 20.3 m0 -92.2 162.59 14.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -136.94 127.15 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.95 135.83 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.728 ' HB2' HD21 ' A' ' 122' ' ' LEU . 7.8 tt0 -96.03 134.93 23.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -8.42 23.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.252 . . . . 0.0 112.329 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -58.11 111.64 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 55.8 mt -81.52 113.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.31 154.03 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.41 108.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.906 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 130.08 -50.92 0.87 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -133.91 128.09 33.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.586 ' C ' HD13 ' A' ' 191' ' ' ILE . . . -118.63 -169.99 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -117.99 -175.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.171 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 191' ' ' ILE . 2.8 mt-10 66.76 55.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.436 ' NE2' HE21 ' A' ' 196' ' ' GLN . 8.2 tt0 -125.76 91.52 48.26 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.631 0.729 . . . . 0.0 110.934 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.756 ' O ' HG22 ' A' ' 147' ' ' THR . 53.6 Cg_endo -69.77 -48.93 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.48 54.02 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.46 ' CD ' ' HB2' ' A' ' 119' ' ' ALA . 6.2 tp-100 -94.91 134.06 37.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -137.29 135.73 37.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.24 117.8 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.168 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -128.23 115.54 18.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.56 129.12 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -72.95 152.13 41.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.51 131.43 52.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.73 125.95 53.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 134' ' ' LEU . 50.6 mm -75.09 142.25 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.21 158.54 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.3 pttp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 -179.993 . . . . . . . . 0 0 . 1 stop_ save_